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Abstract
Regulation of sodium reabsorption in kidney is crucial for maintenance ofwhole body
fluid homeostasis. The Na+ transport induced by aldosterone, either in vivo or in vitro,
is sensitive to the K+-sparing diuretic amiloride, which blocks the epithelial Na+
channel (ENaC). ENaC comprises three homologous subunits (a, (3 and y). Each
subunit is composed of two transmembrane domains, an extracellular loop and short
N- and C-termini. The major renal site of aldosterone action is in the distal nephron,
including the second half of distal convoluted tubules, the connecting tubules, the
cortical and medullary collecting ducts. Two phases are distinguished in its regulation
of sodium transport: an early phase starting after a lag period of 20 to 60 minutes,
during which the pre-existing channels are activated; and the late phase (>3h) is when
de novo synthesis ofENaC and its translocation to the plasma membrane take place.
Aldosterone influences expression of a broad pool of genes, the protein products of
which transduce the actions of aldosterone in the nucleus out to the plasma membrane
where its final effector ENaC is located. The serine-threonine kinase sgkl was
recently identified as a gene rapidly induced by aldosterone, resulting in increased
sodium transport in vitro. To carefully localize and quantify the renal sgkl expression
response to aldosterone, I have performed in situ hybridization on kidneys of mice
having aldosterone excess over a range of doses and durations. In control and
adrenalectomized animals, the glomeruli and inner medullary collecting ducts are the
major sites of sgkl expression, which is maintained independent of aldosterone. Sgkl
upregulation induced by aldosterone excess exhibits spatial-temporal heterogeneity.
Both acute (3 hours) and chronic (6 days) aldosterone excess stimulates sgkl
expression in the distal nephron, i.e. from the distal convoluted tubules through to the
outer medullary collecting ducts. Treatments for 6 days with low sodium diet [0.03%
(I)] and aldosterone infusions [50pg/kg/day (II), 150pg/kg/day (III) and 750ug/kg/day
(IV)] generate elevation of circulating aldosterone. Across these treatments (I-IV), the
circulating level correlates with the progressive induction of sgkl expression, with
highly stimulated tubules first appearing in cortex (I) and continuing downward (II)
until there is a strong stimulation throughout outer medulla (III-IV). Interestingly,
chronic but not acute aldosterone excess causes a slight increase of sgkl expression in
glomerulus (30%-50%, p<0.01), and a dramatic down-regulation in the initial portion
of inner medulla, which could result from diminished interstitial osmolarity. Relative
quantification (vs control) of sgkl upregulation in individual tubules reveals: (1) a
1.8-fold increase of sgkl rnRNA at 3 hours (150pg/kg injection); (2) a dose-
dependence of chronic upregulation reaching a ceiling of 8-fold elevation.
In addition to sgkl, I have screened through 21 novel candidate genes (including 29
isoforms in total) by in situ hybridization and reported the identification of U 12b, a
glutathione S-transferase isoform, as being downregulated by aldosterone.
To elucidate the molecular events underpinning ENaC translocation to and from the
plasma membrane and their hormonal regulation (including corticosteroids and
vasopressin), I have generated stable mouse collecting duct cell (M-l) lines that
express an N-terminally fused EGFP-ENaCp subunit. The cell lines grow normally,
express easily visualized quantities of the EGFP fused ENaC subunit and form
confluent epithelia with high transepithelial resistance when grown on semi¬
permeable filters. Imaging by confocal microscopy revealed that ENaC was confined
to the endoplasmic reticulum (ER) in unpolarized M-l cells. Activation of the
vasopressin pathway results in ENaC exodus from the ER into intracellular vesicles
and this stimulated ENaC trafficking does not involve the endocytic vesicle pathway.
When cells are fully polarized, ENaC largely exits the ER and the Golgi apparatus.
Corticosteroids (>100nM dexamethasone) profoundly alter the trafficking of ENaC
proteins in polarized M-l cells by promoting ENaC translocation to the apical
membrane. Collectively, polarization, corticosteroids and vasopressin modulate the
trafficking of ENaC in distinctive manners such that vasopressin or polarization
fosters ENaC trafficking from ER to intracellular vesicles, whereas corticosteroids
play a role further downstream in the cascade of ENaC trafficking events by
increasing delivery of ENaC to the apical membrane.
In unpolarized distal nephron M-l cells, I have found that sgkl has no effects on
ENaC intracellular trafficking. In addition, sgkl itself is localized to intracellular
compartment distinct from ENaC. To elucidate the role of sgkl in modulating ENaC
conductance, I have generated M-l cell lines stably express sgkl whose gene
expression level is tightly controlled by the tetracycline-inducible system. In these cell
lines, sgkl gene has no 'leaky' expression and its expression induction is highly
responsive to tetracycline (10-fold induction at <10ng/ml versus lOpg/ml). This
model can become available and widely accessible to determine whether upregulation
of sgkl by tetracycline influences ENaC-mediated sodium reabsorption in parallel to
that by corticosteroids.
Outcomes of my PhD project have contributed to our understanding the signaling
pathway of aldosterone and its influences on sodium transport in the distal nephron. It
has also shed light on the roles of sgkl in kidney and the trafficking of
transmembrane proteins involved in ion transport such as ENaC in unpolarized and
polarized epithelial cells; and how these processes are regulated by hormones and
genes whose products mediate the transduction of hormonal signals to altered
trafficking events.
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CHAPTER 1 INTRODUCTION
1.1 THE ROLE OF KIDNEY IN CONTROL OF EXTRACELLULAR
FLUID VOLUME
1.1.1 Control of Extracellular Fluid Volume
Extracellular fluid (ECF) volume is maintained within narrow ranges in normal
humans, despite day-to-day variations in the dietary intake of salt and water over a
wide range (Halperin ML et al 1986). Plasma volume, in turn determined by the total
ECF volume and the partitioning of this volume between extravascular and
intravascular compartments according to the dictates of the Starling relationship, also
remains remarkably constant despite alterations in dietary salt intake. The relationship
of ECF volume and, in particular, the volume of the plasma compartment to overall
vascular capacitance determines fundamental indices of cardiovascular performance
such as mean arterial blood pressure and left ventricular filling volume.
In a given steady state, total daily Na+ intake and excretion are equal. Acute
deviations from a pre-existing normal steady state, consequent to an alteration in Na+
intake or extrarenal excretion, result in an adjustment in renal Na+ excretion. This
adjustment in renal Na+ excretion occurs as a result of a new total body Na+ content
and ECF volume, and aims to restore the body fluid balance back within the normal
limits. The establishment of a new steady-state level of Na4 excretion reflects a new
total body Na+ content and ECF volume. Alternatively, an alteration in the capacitance
of the extracellular compartment affecting circulatory filling can also result in an
adjustment in renal sodium excretion, which thereby can restore normal circulatory
hemodynamics (Bonventre JV et al 1982; Guyton 1990, 1991; Hall JE et al 1986(a)).
It is clear that the operation of such a system for Na+ homeostasis requires 1) sensors
that detect changes in ECF volume relative to vascular and interstitial capacitance and
2) effectors that ultimately modify the rate of Na+ excretion by the kidney to meet the
demands of volume homeostasis. Adjustments in effector mechanisms occur in
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response to perceived alterations in sensory input, with the aim of optimizing
circulatory perfonnance. Derangements in either sensor or effector mechanisms
therefore can lead to disordered Na+ balance and disruption of optimal circulatory
homeostasis (Figure 1.1).
1.1.1.1 Sensors for Fluid Homeostasis
Afferent sensors for fluid homeostasis comprise the cardiopulmonary and arterial
baroreceptors as well as central nervous system, renal and hepatic sensors (Goetz KL
et al 1970; Paintal AS et al 1973; Linden RJ 1979; Gross R et al 1980; Beers ET et al.
1986; Skott O et al 1987; Passo SS et al 1973). Each compartment can be viewed as
reflecting a unique characteristic of overall circulatory function, such as cardiac fdling,
cardiac output and renal perfusion. Sensors within each compartment monitor a
physical parameter (e.g., stretch, tension) that serves as an index of circulatory
function within that compartment. Signals emanating from afferent sites engage
efferent mechanisms that affect compensatory changes in renal Na+ excretion. Volume
expansion results in an integrated sequence of reflex and hormonal responses that
enhance the renal excretion of salt and water. Conversely, the reflex response to
volume contraction is renal conservation of salt and water.
1.1.1.2 Effectors for Fluid Homeostasis
Efferent effectors for fluid homeostasis comprise adjustments in the glomerular
filtration rate (GFR) and changes in the factors that affect reabsoiption of filtered
electrolytes and water. These encompass not only the physical factors common to
reabsorption from all capillary beds (including capillary permeabilities, hydrostatic
and osmotic gradients contributing to the net peritubular capillary Starling forces), but
also those unique to the nephron governing transepithelial transport via both
paracellular and transcellular routes. Regulation of GFR, transepithelial and capillary
reabsorption in response to afferent stimuli is incompletely understood but utilizes
efferent signaling via nerves and hormones (that include the renin-angiotensin-
aldosterone system, vasopressin, natriuretic peptides and endothelins) (Rector FCJ et
2
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Figure 1.1 Overall scheme for body Na+ balance and partitioning of extracellular
fluid volume. In the setting of normal osmoregulation, extracellular Na+ content is
the primary determinant of extracellular fluid volume. Overall Na+ homeostasis
depends on the balance between loss and intake. Renal Na+ excretion, in turn, is
determined by the balance between filtered load and tubule reabsorption. This latter
balance is modulated under the influence of effector mechanisms, which, in turn,
are responsive to sensing mechanisms that monitor the relationship of the
extracellular fluid volume to capacitance. ECFV = extracellular fluid volume.
al 1996; Burg MB et al 1968; BankN et al 1984; Guyton 1990, 1991; Ardaillou R et
al 1997; ReifMC et al 1986).
1.1.2 Renin-Angiotensin-Aldosterone System
The renin-angiotensin-aldosterone system plays a pivotal role in the regulation of
ECF volume and Na+ homeostasis. This system is activated in situations that
compromise extracellular volume homeostasis, such as reduced ECF and circulatory
volumes, low sodium intake, hypotension, and an increase in sympathetic nerve
activity. The kidney is both an important source of several components of the renin-
angiotensin system and a target organ for their actions. The juxtaglomerular cells are
the major site of renin synthesis and release. Angiotensinogen is produced primarily
from the liver and less from the kidney and the adipose tissue. Angiotensin-converting
enzyme, which cleaves angiotensin I (Al) to All, is found in large amounts in the lung,
but is also found in the brush border of proximal convoluted tubules of the kidney and
in endothelial cells of many organs, including the kidney. Al is rapidly converted to
All in the lungs and other extrarenal tissues, as well as in the kidney (Figure 1.2). All
exerts multiple direct intrarenal influences, including renal vasoconstriction,
stimulation of tubular epithelial Na+ reabsorption, augmentation of tubular-glomerular
feedback (TGF) sensitivity, and modulation of pressure-natriuresis (Ardaillou R et al
1997; Blantz RC et al 1976; Chou SY et al 1990; Hall JE 1986(b); Schuster VL et al
1984; Olsen ME et al 1985). Importantly, All stimulates the synthesis of aldosterone
that has major effects in augmentation of long-term renal sodium reabsorption.
1.2 THE ROLE OF THE ALDOSTERONE PATHWAY IN THE
MAINTENANCE OF SODIUM HOMEOSTASIS
1.2.1 Synthesis ofAldosterone
Aldosterone is a steroid synthesized in the zona glomerulosa region of the adrenal
cortex, and, because it is not stored, regulators of aldosterone secretion act by
controlling various steps of aldosterone synthesis. The adrenal production of
3
The Ren in-angiotensin system
kidney
Figure 1.2. The Renin-Angiotensin-Aldosterone System
aldosterone is catalyzed by a synthetic pathway largely of enzymes from the
cytochrome P450 family (CYPs). Angiotensin II is the principal circulating effector of
increased aldosterone secretion. It acts by stimulating the G protein-PKC cascade,
leading to an influx of extracellular calcium (Quinn SJ and Wiliams GH 1988). These
events increase the conversion of corticosterone to aldosterone (catalyzed via the
enzyme CYP11B2 or aldosterone synthase) in the aldosterone systhesis pathway
(McKenna TJ et al. 1978; Kramer RE et al. 1980; Quinn SJ and Wiliams GH 1988)
(Figure 1.3). In addition to angiotensin II, elevated potassium also has powerful
stimulatory influences, whilst other factors play a more minor role in aldosterone
secretion (such as short-term stimulation by ACTH and repression by dopamine)
(Figure 1.2).
1.2.2 Physiology ofAldosterone Action
The most important and conserved functions of aldosterone are to promote sodium
reabsorption and to promote potassium secretion across certain 'tight' epithelia, that is,
epithelia that display a high transepithelial electrical resistance and an amiloride-
sensitive, electrogenic sodium transport. In mammals, such epithelia are found in the
distal part of the nephron and the intestine, and the ducts of exocrine glands (salivary,
mammary and sweat glands). Using receptor localization techniques, the aldosterone
sensitive distal nephron (ASDN) has been reported as including the late distal
convoluted tubules (DCT) and connecting tubules (CNT) through to the cortical
collecting duct (CCD), and to a lesser extent the outer medullary collecting duct
(oMCD) (Doucet A et al 1981; Farman N 1992) (Figure 1.4).
Aldosterone action is best understood in collecting ducts (CD), which are composed
of two cell types: principal cells and intercalated cells (further subdivided into a and P
cell types). Principal cells reabsorb Na+ and H2O, secrete K+ and express the
amiloride sensitive epithelial sodium channel (ENaC) and the Na+/K+-ATPase.
Intercalated cells either secrete H+ (a type) or reabsorb HCO3" (P type) and thus are
important in regulating acid-base balance. Aldosterone diffuses freely across the





































Figure 1.3. Corticosteroid biosynthesis pathways in adrenal cortex. CYP, cytochrome P450
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transported into the nucleus and binds to specific steroid-responsive elements (SRE)
within the promoters of a number of genes. The interaction of the steroid-receptor
complex with the transcription machinery leads to an increase in transcription and to
the accumulation of corresponding rnRNA, which are, in turn, translated into proteins,
a key subset of which mediate Na reabsorption and K secretion (Farman N et al 2001;
Fuller PJ et al 2000; Funder JW 1997) (Figure 1.5).
1.2.3 Temporal Phases of Aldosterone Action
The genomic actions of aldosterone are traditionally divided into an early and late
phase (Verrey F et al 1995, 1999, 2000). The early phase is predicted to respond to
acute changes in salt and water balance to allow for more rapid responses to
movements away from homeostasis. The early phase of aldosterone action is most
often demarcated as the period where Na transport is increased without an
accompanying increase in the expression levels of the transporter proteins involved in
this action. This phase directly follows the 10-20 min latent period required for
changes in gene expression and proceeds for 2-4 h. The late phase, then, is classified
as that following this period and is when the de novo synthesis of transporter proteins
takes place, such as ENaC and the Na+/K+-ATPase (Feraille E et al 2001; Verrey F et
al 1995, 1999, 2000). Moreover, a prolonged phase developing over days and even
weeks is often regarded as the very late phase when tubular hypertrophy is observed.
1.2.3.1 Early actions ofaldosterone.
The initial actions of aldosterone with respect to increasing Na reabsorption and K
secretion are mediated by stimulating the existing transporter proteins. There are
ultimately only two such ways aldosterone can enhance transport: 1) by increasing the
open probability of apical ion channels and the activity of the basolateral Na+/K+-
ATPase and 2) by increasing the number of ion channels and Na+/K+-ATPase in the
cell membrane. There is considerable evidence regarding both mechanisms of
aldosterone action in ASDN (Dijkink L et al 1999; Frindt G et al 2001; Garty H et al





Figure 1.5. Aldosterone action in distal nephron cells. Aldo:
aldosterone; AIP: aldosterone induced proteins; ENaC: epithelial
sodium channel.
TR et al 1992, 2001; Weisz OA et al 2000).
1.2.3.2 Late actions ofaldosterone.
During the late phase of aldosterone action, there is a clear increase in the amount of
ENaC protein within the cell, as well as at the apical membrane (Weisz OA et al 2000;
Loffmg J et al 2000; Masilamani S et al 1999). Aldosterone induces expression of the
genes encoding the a subunit of ENaC (Asher C et al 1996; Escoubet B et al 1997)and
the al- and pi-subunits of the Na+/K+-ATPase (Kolla V et al 1999, 2000; Blot-
Chabaud M et al 2001). In addition to upregulation in these transporter proteins,
enzymes essential to energy metabolism also increase in response to aldosterone
(Feraille E et al 2001; Verrey F et al 1995, 2000). All three actions (i.e. energy
metabolism, protein synthesis and protein trafficking) combine to program cells for
prolonged ion transport.
1.2.4 Maintenance of sodium balance by pressure natriuresis during
aldosterone escape
Excessive secretion of mineralocorticoids, or infusion of mineralocorticoids such as
aldosterone causes sodium and water retention and gradual elevation of arterial
pressure. Such sodium and water retention lasts for a few days depending on sodium
intake and the severity of hormone excess, and is followed by an 'escape' in which
sodium excretion returns towards normal despite continual mineralocorticoid excess.
A classic experiment performed by JE Hall and AC Guyton indicates the essential role
of pressure natriuresis in regulating sodium balance during mineralocorticoid escape
(Hall JE et al. 1986a). In control animals, sodium excretion decreased transiently but
returned towards normal on the second day of aldosterone infusion. After 7 days the
cumulative sodium balance and arterial pressure was only slightly elevated. In
contrast, when renal perfusion pressure was servocontrolled (kept constant and
separated from the increase of systemic pressure) during infusion, sodium excretion
remained suppressed and cumulative sodium balance continued to increase
throughout the 7 days of treatment. It is clear that sodium transport in distal nephron
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persists to increase during such an event (Tornita K et al. 1985). The site of
compensatory reduction in sodium reabsorption allowing this 'escape' is not entirely
clear but seems to involve tubules of the more proximal nephron and contribution by
adjusting the rates of glomerular filtration (Wright FS et al. 1969; Kohan DE et al.
1980).
1.2.5 Components of the Aldosterone Pathway and its Molecular
Mechanism
1.2.5.1 Corticosteroid Receptors
Aldosterone, as a mineralocorticoid, is a high affinity ligand for the mineralocorticoid
receptor (MR) and it has considerably weaker affinity for the related glucocorticoid
receptor (GR), a receptor activated almost exclusively by the 100-1000 higher level of
glucocorticoids (Fuller PJ et al 2000; Funder JW 1997). It is clear that the potent
glucocorticoid inactivating enzyme (11 |3-hydroxysteroid dehydrogenase type 2)
confers aldosterone specificity in many aldosterone target tissues such as the distal
nephron (Funder et al 1988, Brown RW et al 1996(a,b)).
MR and GR translocate to the nucleus in a ligand-dependent manner, form
homodimers and function as transcription factors through interaction with genomic
DNA at a steroid response element (SRE; consensus sequence
AGAACAnnnTGTTCT). Two distinct molecular mechanisms are widely accepted to
define the actions of corticosteroid receptors (MR and GR) on gene expression: 1) the
classic mechanisms involving trans-activation and trans-repression via interaction
with cognate DNA-binding sites, such as SRE and 2) mechanisms of transcription
interference and synergy mediated by protein-protein interactions between
corticosteroid receptors and other trans-acting factors.
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1.2.5.1.1 Transactivation
The cA-acting elements responsive to corticosteroid receptors for many
corticosteriod-induced genes have now been identified. A corticosteroid-sensitive
gene encodes serum and glucocorticoid-inducible kinase (Chen S et al 1999; Maiyar
AC et al 1997; Webster MK et al 1993, 1993(a)). The promotor region of the human
sgkl gene contains a classic but imperfect pentadecameric cA-acting SRE (AGGA-
CAgaaTGTTCT; Maiyar AC et al 1997; Webster MK et al 1993a). In mammary
epithelia, this element is tra/is-activated in response to dexamethasone signaling
(Webster MK et al 1993(a); Maiyar AC et al 1997). Indirect evidence from numerous
epithelia, including the renal distal nephron and distal colon, indicates that this cis-
element is also responsive to aldosterone via MR (Bhargava A et al 2001; Brennan FE
et al 2000; Chen S et al 1999; Loffing J et al 2001; Shigaev A et al 2000). That
glucocorticoids and aldosterone via GR and MR trans-activate sgkl in distinct tissues
possibly through a common SRE suggests that both types of steroid may initiate a
cellular response mediated by a common signaling pathway or one that contains many
common signaling elements. Thus GR and MR likely have, at least partially,
overlapping functions in epithelia expressing both receptors. Functional redundancy
or promiscuity is supported, nevertheless, by findings showing that aldosterone via
MR and glucocorticoids via GR induce expression ofmany of the same genes and that
the widely expressed GR is sometimes capable of complementing MR dysfunction or
eliciting a mineralocorticoid response, especially in in vitro propagated cell lines (see
below 1.2.5.1.4) (Kunzelmann K et al 1999; Chen SY et al 1998; Ferrari P et al 2000;
Funder JW 1997; Holmes MC et al 2001; Lifton RP et al 2001; Rogerson FM et al
2000). A corticosteroid-sensitive gene also encodes the a-subunit of ENaC (Dagenais
A et al 2001; Mick VE et al 2001). A classic but slightly imperfect SRE
(AGAACAgaaTGTCCT) was recently identified as sufficient and necessary for trans-
activation of the human and rat a-ENaC promoters in renal, lung, salivary, and
colonic epithelial cell lines (Lin HH et al 1999; Mick VE et al 2001; Sayegh R et al
1999; Wang HC et al 2000; Zentner MD et al 2001). This cA-acting element is




Glucocorticoids via GR repress expression of a host of genes. Recent studies also
have identified several aldosterone-repressed genes and proteins (Laverty G et al 2001;
Robert-Nicoud M et al 2001; Spindler B et al 1997). Compared with induction, less is
known about the molecular mechanisms of direct gene repression in response to
corticosteroids. The term "negative"-SRE (nSRE) is used sometime to define the ex¬
acting element that directly mediates trans-repression in response to glucocorticoid
signaling via GR. GR interacts directly with the 5'-
ATTTTTGTCAATGGACAAGTCATAAGAA-3' nSRE sequence in the promotor
region of the corticotropin-releasing hormone (CRH) gene to tra/x-repress cAMP
activated expression of CRH (Malkoski SP et al 1996, 1997). The nSRE in the gene
encoding proopiomelanocortin (POMC; 5'-GGAAGGTCACGTCCA-3') has also
been identified (Charron J et al 1986; Drouin J et al 1989, 1993). The effects of MR
on these nSREs have not been studied, and thus it remains to be determined whether
MR is capable of modulating expression via these sorts of nSREs. The recent
identification of a number of putative aldosterone-repressed genes and proteins
(Laverty G et al 2001; Robert-Nicoud M et al 2001; Spindler B et al 1997) points to
possible candidates worthy of further investigation in this regard.
1.2.5.1.3 Protein-protein interactions during MR and GR modulation of
gene expression
The (3-casein gene is induced by GR independently of an SRE (Stoecklin E et al 1997).
The mechanism of action here entails GR "tethering" through a protein-protein
interaction to a transcription factor itself binding the promoter called Stat-5 (signal
transducer and activator of transcription-5). Induction of P-casein in response to
glucocorticoids, then, is actually dependent on formation of GR/Stat-5 complexes that
bind to Stat-5 response elements. GR forms an equivalent type of complex with the
transcription factor Oct-2 (organic cation transporter-2) (Prefontaine GG et al 1998)
and has also been reported to associate with Stat-3 (Zhang Z et al 1997). It is not
known whether MR also binds these and/or other such tethering factors, and thus such
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a mechanism of action involving transcription synergy for MR is purely speculative at
this time. If MR has limited interaction with these tethering factors or interacts with
distinct ones, this mechanism might then distinguish between GR and MR responses.
Ample results demonstrate that GR negatively influences the actions of activator
protein (AP)-l and nuclear factor (NF)-kB on transcription via direct protein-protein
interactions (Karin M et al 1998, 2001). The functional consequence of protein-
protein interactions involving GR in vivo have been clarified by the use of a
transgenic mouse model containing mutant GR incapable of forming dimers (GRdim),
which thus cannot bind and trans-activate at SREs (Heck S et al 1994; Karin M.
1998). Also, frvms-repression of POMC and prolactin via nSRE is compromised in
GRd'm/dim mjce_ i1L1t these mice retain the ability for ligand-activated GR to interfere
via protein-protein interactions with transcription initiated by other trans-acting
factors (Reichardt HM et al 1998). Indeed, the ability of activated GR via AP-1 to
interfere with tra/rs-activation of genes encoding collagenase and gelatinase is
retained in GRd,m/dim mice. The ability of GR to interfere with NF-kB activity also is
retained in GRdim/dim mice. It is presently unclear whether MR has such an ability to
mediate some of its cellular actions via protein-protein interactions involved in
transcription interference and/or synergy. In addition, Maiyar AC et al (1997) recently
identified a novel mechanism of reciprocal interference between GR and the p53
protein. Induction of sgkl by GR signaling is abrogated by simultaneous activation of
p53. p53 interferes with GR via protein-protein interactions by preventing its
interaction with its cognate SRE.
1.2.5.1.4 Promiscuity vs Specificity of physiological response to
mineralocorticoids and glucocorticoids
Because MR and GR are homologous, and because they have overlapping functions
in epithelia expressing both receptors, it is sensible to ask whether they might be
redundant. Knocking out the GR resulted in mice that died a few hours after birth
(Cole TJ et al 1995). They exhibited profound impairment of lung maturation and lack
of activation of genes of key gluconeogenic enzymes. The phenotype of MR-
knockout mice was different (Berger S et al 1998): during the first few days of the
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postnatal period, there was a progressive syndrome of sodium and water loss, with
weight loss, hyperkalemia, and hyponatremia (reflecting human
pseudohypoaldosteronism), leading to death. Interestingly, the MR knockout mice can
be rescued by sodium chloride injections but not glucocorticoids (Bleich M et al
1999). These experiments clearly show that each of these receptors has, at least some,
specific functions that cannot be fulfilled by the remaining receptor in vivo.
Nevertheless, there are well established cell culture and in vitro systems where
upregulation of epithelial sodium reabsorption is strongly driven by corticosteroids
(glucocorticoids or mineralocorticoids) acting via GR, such as in Xenopus A6 renal
cells, frog skin and toad bladder (May A et al 1997; Schmidt TJ et al 1993); and in
cultured mammalian collecting duct cells (including rat, rabbit and mouse) (Laplace
JR et al 1992; Naray-Fejes-Toth A et al 1990, 2000), as the expression of MR in
cultured cells or in vitro is largely reduced or silenced.
Thus, in study of the signaling pathway of aldosterone, I have used experimental
models involving aldosterone stimulation of sodium reabsorption in vivo in mouse
kidney; and a validated cell culture model (mouse collecting duct M-l cells: Stoos BA
et al 1991) involving glucocorticoid stimulation of sodium reabsorption in vitro.
1.2.5.1.5 Non-genomic aldosterone action
According to the traditional model, aldosterone binds to intracellular receptors and
subsequently modulates transcription and protein synthesis, thus triggering genomic
events. In addition, very rapid effects (developing over seconds or minutes) of
aldosterone mainly affecting intracellular signaling are widely regarded as being
incompatible with the genomic model. These effects involve a surge of intracellular
2+Ca release and production of inositol-1,4,5-trisphosphate (IP3) and diacylglycerol
(DAG) in collecting duct cells, vascular smooth muscle cells and aortic endothelial
cells (Wehling M et al 1991; Estrada M et al 2000; Harvey BJ et al 2000). These rapid,
non-genomic aldosterone actions are independent of actinomycin D (transcription
inhibitor), cycloheximide (translation inhibitor) (Wehling M et al 1991) and classic
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MR (Haseroth K et al 1999), thus likely to be transmitted via specific but unidentified
membrane receptors. Nevertheless, the actions of aldosterone on electrolyte transport
are mediated via MR (blocked by MR antagonist) and requiring new gene expression
(blocked by actinomycin D or cycloheximide). Thus there is little doubt that the
sodium retaining effects of aldosterone occur via the nuclear receptor MR involving
classic genomic events.
1.2.5.2 UP-HSD2
Despite the fact that the circulating level of aldosterone is normally 100- to 1,000-fold
less than that of glucocorticoids, MR in kidney is selectively occupied by aldosterone.
This apparent contradiction can be explained by the presence of a glucocorticoid-
converting enzyme, 1 ip-hydroxysteroid dehydrogenase type 2 (11|3-HSD2). This
enzyme catalyzes the conversion of the active 11-hydroxycorticosteroids (Cortisol and
corticosterone) to 11-oxo-corticosteroids (cortisone and 11-dehydrocorticosterone
respectively), which have a much lower affinity for the corticosteroid receptors and
are thus effectively inactive (Funder JW et al 1988; Brown RW et al 1996(a,b)). The
renal cellular distribution of 11 |3-HSD2 essentially parallels that of the MR (Albiston
AL et al. 1994).
1.2.5.3 Aldosterone Induced Proteins (AIP)
Aldosterone influences expression of a broad pool of genes, the protein products of
which participate in aldosterone signaling and alter ion transport in the plasma
membrane of distal nephron, where its final effectors (ENaC and Na+/K+-ATPase) are
located (Verrey F 2000; Pearce D 2001). A number of aldosterone induced genes have
been identified in kidney or renal cell lines, which include sgkl, Ki-ras, GILZ,
NDRG2, ENaC and Na+/K+-ATPase (discussed next in detail).
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1.2.5.3.1 Sgkl
REGULATION Of the recently identified aldosterone-induced genes, sgkl has
attracted the most attention. This gene was identified originally in fibroblasts and
mammary epithelia as an immediate-early gene induced by glucocorticoids at the
level of transcription independently of de novo protein synthesis (Webster MK et al
1993, 1993(a)). Subsequent work by Chen S et al (1999) and Naray-Fejes-Toth A et al
(2000) identified sgkl as a primary aldosterone-induced gene in amphibian and
mammalian renal epithelia. This transcript also is strongly induced by corticosteroids
throughout the gastrointestinal tract but not the lungs (Shigaev A et al 2000; Brennan
FE et al 2000). The sgkl transcript is also commonly expressed in many nonepithelial
tissues in a corticosteroid-insensitive manner, suggesting that sgkl expression has
very different regulation and may be constitutive (Chen S et al 1999; Webster MK et
al 1993). Corticosteroids, through both GR and MR, increase sgkl levels within 10-30
min of treatment, with levels peaking after 1 -2 h and returning to pretreatment values
soon afterward. Induction by aldosterone of Sgkl protein in renal epithelia follows a
similar time course, with protein levels increasing within 10-30 min, peaking by 6 h,
and returning to pre-treatment levels by 24 h (Chen S et al 1999). Sgkl itself is a
phosphoprotein, with phosphorylation at threonine-256 and serine-422 by PDK-1
being required for Sgkl activity. Aldosterone increases both absolute and phospho-
Sgkl levels in renal A6 cells (Wang J et al 2001). The lipid/protein kinase PI3K is
upstream of PDK-1 in the PI3K signaling cascade and is required for activation of
PDK-1 and Sgkl by insulin, insulin-like growth factor (IGF)-l, and other stimuli
(Park J et al 1999). Thus Sgkl is a constituent of the PI3K signaling cascade
positioned downstream of PDK-1 in parallel with PKB/Akt (Kobayashi T et al 1999;
Vanhaesebroeck B et al 2000). In renal A6 epithelia, inhibition of PI3K attenuates
aldosterone-induced increases in Na transport and in the active (phosphorylated) but
not absolute levels of Sgkl (Wang J et al 2001). This maneuver also blocks activation
of Sgkl and Na transport by insulin in the same cells. Sgkl localizes to both the
cytosol and nucleus and has proposed roles in preventing apoptosis and promoting
cell proliferation in mammary tumor cells (Alliston TN et al 2000; Buse P et al 1999;
Gonzalez-Robayna IJ et al 1999; Mikosz CA et al 2001; Park J et al 1999). It is
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unclear how such an action could ultimately lead to increased transport if it were
manifest in sodium transporting epithelia.
FUNCTION Sgkl is a serine/threonine kinase that shares much homology
with protein kinase B (PKB)/Akt kinases and phosphorylates at a consensus sequence
(RXRXXS/T; optimal site KKRNRRLSVA) similar to that targeted by PKB/Akt,
protein kinase C, and p90 ribosomal protein S6 kinase (Park J et al 1999; Kobayashi T
et al 1999(a)). Several laboratories have shown that overexpression of Sgkl with
ENaC in the heterologous X. laevis oocyte expression system leads to increase of the
channel conductance (Chen S et al 1999; De La Rosa DA et al 1999; Loffing J et al
2001; Naray-Fejes-Toth A et al 1999; Shigaev A et al 2000; Wagner CA et al 2001).
Wulff P et al (2002) generated a knockout mouse model of sgkl. Sgkl '" mice show
no gross functional abnormalities and have normal Na and K metabolism when
maintained on a normal diet. Nevertheless these animals showed inappropriate Na
wasting when stressed with a low-Na diet. These studies suggest that sgkl plays a
pivotal role in linking aldosterone to the hormone driven Na reabsorption. In Xenopus
oocytes, sgkl increases the number of co-expressed ENaC in the plasma membrane
independently of overt effects on the gating kinetics of this channel (De La Rosa DA
et al 1999; Loffing J et al 2001; Wagner CA et al 2001). Initial thoughts about the
mechanism of action of Sgkl included the notion that it directly interacted and
phosphorylated ENaC to dynamically regulate ENaC insertion into and/or retrieval
from the apical membrane. Indeed, Sgkl physically interacts with the COOH termini
of both a- and p-ENaC, when the latter proteins are expressed as glutathione S-
transferase fusion proteins (Wang J et al 2001). However, attempts to phosphorylate
native as well as in vitro transcribed/translated ENaC with active, purified,
recombinant Sgkl have been unsuccessful to date (Chigaev A et al 2001; Stockand JD
et al 2001). Because introduction of mutations to ENaC that results in loss of ENaC
retrieval from the membrane to the lysosome and/or proteosome does not abrogate
Sgkl actions on the channel in oocytes (Chigaev A et al 2001; De La Rosa DA et al
1999; Shigaev A et al 2000), it is more likely that this kinase regulates ENaC insertion.
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SUBSTRATE The substrates of Sgkl and those that physically interact with
Sgkl largely remain unspecified. Zhang et al. (Zhang BH et al 2001) recently
identified B-Raf as a substrate of Sgkl. In addition to B-Raf, the Forkhead family
member FKHRL1, a proapoptotic transcription factor, is targeted by Sgkl (Brunet A
et al 2001). A role for regulation of FKHRL1 by Sgkl during a mineralocorticoid
response is presently unclear. The ubiquitin ligase NEDD4 directly interacts with the
COOH termini of ENaC subunits at the PY motif and targets this channel for
degradation (Staub O et al 1997, 2000). Debonneville C et al (2001) recently showed
that Sgkl directly interacted with NEDD4—2 to inhibit the latter protein's function and
its binding to ENaC, which was independently reported by Snyder PM et al (2002).
However, conflicting data show that mutations or deletions within ENaC COOH
termini that destroy the NEDD4-binding site do not interfere with Sgkl activation of
these channels in oocytes (De La Rosa DA et al 1999; Loffing J et al 2001; Wagner
CA et al 2001). Resolution of this apparent controversy is paramount to understanding
Sgkl actions on ENaC.
ISOFORMS OF SGK The recent development of SgkL" mice has confirmed
that SGK1 is a physiologically important mediator of aldosterone effects on renal
sodium handling (Wulff P et al 2002). However, the Sgk knockout mouse has far less
severe sodium wasting (only occurring when challenged with low-sodium diet) than
the MR knockout (Berger S et al 1998), suggesting that other factors also mediate MR
regulation of sodium transport. These factors may include two other forms of Sgk
(Sgk2 and Sgk3), both of which are expressed in the kidney (Kobayashi T et al
1999(b); Liu D et al 2000; Dai F et al 1999). However, preliminary studies have failed
to show responsiveness of Sgk2 and Sgk3 to corticosteroids (Kobayashi T et al
1999(b)). One recent study has found that Sgk2 and Sgk3 both stimulate ENaC
mediated Na+ current in Xenopus oocytes (Friedrich B et al 2003). Hence, it seems
likely that Sgk2 and/or Sgk3 are implicated in either basal or hormone-regulated Na
transport in the kidney. Whether either is a mediator of aldosterone action remains to
be determined.
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A diagram summarizing the role of Sgkl in the pathway of aldosterone is shown in
Figure 1.6.
1.2.5.3.2 Ki-RasA
REGULATION Spindler B et al (1997) identified Ki-ras A splice variant as an
aldosterone-induced transcript. Aldosterone induces Ki-RasA during the early phase
of action, with levels rising as early as 30 min after treatment. There are four
homologous Ras proteins: Ha-Ras, N-Ras, Ki-RasA, and Ki-RasB. The latter two
result from splice variants encoded by a common gene (Bar-Sagi D. 2001). Induction
of Ki-rasA is a primary action of aldosterone that is independent of de novo protein
synthesis. Previously, it has been shown that both the Ha-ras and Ki-ras genes were
induced by glucocorticoids (Neades R et al 1991; Pethe V et al 1999; Strawhecker JM
et al 1989). Controversy surrounded the importance of Ki-RasA in aldosterone
signaling. Ki-rasA does not appear common to all epithelia capable of a
mineralocorticoid response. Aldosterone via MR preferentially increases the Ki-RasA
transcript and protein levels in amphibian distal nephron (Spindler B et al 1999) and
via GR in amphibian renal A6 cells (Spindler B et al 1997; Stockand JD et al 1999).
In contrast to these findings, Robert-Nicoud and colleagues (Robert-Nicoud M et al
2001), using serial analysis of gene expression (SAGE), were unable to identify Ki-
Ras as being induced by aldosterone in a collecting duct cell line. Similarly no
evidence of upregulation of Ki-Ras mRNA in kidney was seen by acute or chronic (6
days) aldosterone excess treatment of mice when sgkl exhibited striking upregulation
under the same experimental conditions (Christy C et al 2000). Others have also
found similar negative results in vivo in mice (Verrey F: personal communication).
Unlike Sgkl, the candidacy of Ki-ras as an important intermediary in aldosterone
pathway in mammalian kidney remains in doubt.
FUNCTION Mastroberardino L et al (1998) showed in the heterologous X.
laevis oocyte expression system that overexpression of constitutively active Ki-RasA
with ENaC has conflicting actions on the ion channel, both stabilizing the open














Figure 1.6. Aldosterone pathway in distal nephron. PI3K, phosphatidylinositol 3-
kinase; PDK1, 3-phophoinositide-dependent protein kinase 1; MEK, mitogen
extracellular kinase kinase kinase; MAPK, mitogen activated protein kinase; sgk,
serum and glucocorticoid-induced kinase; ENaC, epithelial sodium channel;
Nedd4-2: ubiquitin protein ligase 4-2.
effect on channel number resulted from nonspecific actions of activated Ki-RasA on
induction of oocyte maturation. Stockand JD et al (1999) demonstrated that induction
of Ki-RasA during the early phase is necessary and sufficient for some part of
aldosterone's action on Na transport in polarized renal A6 epithelial cells. Indirect
evidence from several other studies (Becchetti A et al 2000; Stockand JD et al 2001(a))
suggests that Ras must be in close proximity to ENaC. Alternatively, Ras could signal
to ENaC through effector proteins that are also localized to the plasma membrane. For
example, Ras signaling is known to activate PI3K in numerous cell types (Foschi M et
al 1997; Rommel C et al 1999; Yan J et al 1998) and PI3K activates Sgkl in vitro
(Park et al 1999), which clearly affect ENaC conductance. During chronic activation
of Ras and its downstream effector cascades, specifically the MAPK cascade, ENaC
expression levels are ultimately decreased in both native epithelia and heterologous
systems (Lin HH et al 1999; Mastroberardino L et al 1998; Wang HC et al 2000;
Zentner MD et al 1998).
A diagram summarizing the role of Ki-RasA in the pathway of aldosterone is shown
in Figure 1.6.
1.2.5.3.3 GILZ
Robert-Nicoud et al. (Robert-Nicoud M et al 2001) have identified the glucocorticoid-
induced leucine zipper protein (GILZ) as an aldosterone-induced gene in an
immortalized mouse collecting duct cell line (mpkCCD). GILZ transcript levels were
increased by aldosterone within 30 min, indicating that it is an early response event.
GILZ belongs to the transforming growth factor-(3-stimulated clone 22 (TSC-
22)/DSIP-immunoreactive leucine zipper protein family, thought to be transcription
factors. How GILZ could affect ENaC conductance remains unclear.
1.2.5.3.4 NDRG2
Boulkroun S et al (2002) have identified an early response cDNA highly homologous
to human and murine NDRG2 (N-Myc downstream regulated gene 2), using a
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subtractive hybridization technique on isolated renal cortical collecting ducts from
rats injected with a physiological dose of aldosterone. NDRG2 mRNA was expressed
in classical aldosterone target epithelia (including the kidney) and localized in the
collecting duct, the site of aldosterone-regulated sodium absorption. NDRG2 111RNA
was increased within 45 min by aldosterone in the kidney and distal colon. In the
RCCD2 collecting duct cell line, NDRG2 gene expression was increased as early as
15 min by aldosterone (InM-lOnM) but was not responsive to the glucocorticoid
dexamethasone. The function of NDRG2 and its role in sodium reabsorption remain
unclear.
1.2.5.3.5 ENaC
The regulation of ENaC mRNAs by aldosterone shows tissue-specificity in kidney
and colon. In the distal nephron, aldosterone increases the ENaC a subunit mRNA
without affecting the mRNAs encoding the (3 and y subunits. In contrast, in colon it is
the P and y subunit mRNAs that are upregulated by aldosterone, whereas the a subunit
is expressed constitutively (Asher C et al. 1996; Escoubet B et al. 1997; Renard S et al.
1995). In the Xenopus A6 cell line, aldosterone specifically increases protein levels of
the ENaC a subunit 60 min after treatment. A few hours later, the synthesis of the P
subunit increases as well, but not that of the y subunit (May A et al. 1997; Spindler B
et al. 1997).
The discussion of ENaC and its structure, function and trafficking is elaborated in
more detail in the following chapter.
1.2.5.3.6 Na+/K+-ATPase
The Na+/K+-ATPase belongs to the family of P-type ATPases including Ca2+-
ATPases of the endoplasmic reticulum and H+/K+-ATPases of the plasma membrane.
Na+/K+-ATPase exchanges three intracellular Na+ for two extracellular K+ per cycle
and hydrolyzes ATP. In aldosterone target epithelia, Na+/K+-ATPase consists of the
al and pi subunits (Burgener-Kairouz P et al. 1994). The Na+/K+-ATPase al and pi
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subunit genes have been shown to be regulated by aldosterone in A6 epithelia. The
increase in pi subunit mRNA starts to be measurable after 1 hour of aldosterone
treatment and that of al after approximately 3 hours (Spindler B et al. 1997; Verrey F
et al. 1989). In animals, long-term treatment with aldosterone produces a large
increase in the number of Na+/K+-ATPase subunits and a parallel increase in the
basolateral surface area (El Memissi G et al. 1983; Garg LC et al. 1981; Hayburst RA
et al. 1988; Wade JB et al. 1990; Welling PA et al. 1993). Na+/K+-ATPase activity in
basolateral membrane is also upregulated in distal nephron epithelia in less than 1
hour of aldosterone treatment (Mujais SK et al 1984; Rayson BM et al 1984). This
appears largely relating to enhanced recruitment of existing Na+/K+-ATPase from an
intracellular pool rather than de novo protein synthesis. The mechanism of this
upregulation is not well understood but likely involves the influences of aldosterone
induced proteins and/or the effects of apical entry of sodium and electro-osmotic
changes it elicits (Blot-Chabaud M et al 1990; Coutry N et al 1994).
1.2.6 The Pivotal Importance of Aldosterone Pathway in Control of
Blood Pressure and Clinic Relevance
The identification of genes related to blood pressure variation has contributed
enormously to defining primary physiologic mechanisms underpinning this trait,
thereby helping elucidate pathogenic pathways and targets for therapeutic intervention.
The genetic approach has investigated rare Mendelian forms of blood pressure
variation in which mutations in single genes impart large effects on blood pressure;
and the subsequent genetic engineering to generate transgenic or knockout mouse
models to mirror the human disorders. So far, genetic studies have identified
mutations in more than 10 genes that cause Mendelian forms of hyper- and/or
hypotension. Out of these genes related to hypertension, more than half are involved
in the aldosterone pathway.
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1.2.6.1 Genes Involved in Aldosterone Synthesis
1.2.6.1.1 Glucocorticoid-Remediable Aldosteronism
Glucocorticoid-remediable aldosteronism (GRA) is an autosomal dominant trait
featuring early onset of hypertension with normal or elevated aldosterone levels
despite suppressed plasma renin activity (Sutherland et al., 1966). GRA is caused by a
gene duplication arising by unequal crossing over between two closely related genes
involved in adrenal steroid biosynthesis. The two genes encode aldosterone synthase
and steroid 11 P-hydroxylase, an enzyme involved in Cortisol biosynthesis whose
expression is regulated by adrenocorticotropic hormone (ACTH) (Lifton et al., 1992a,
1992b). The resulting chimeric gene has the promoter of 11 P-hydroxylase and the
coding region of aldosterone synthase. Thus the aldosterone synthase activity is
ectopically expressed under control of ACTH rather than agiotensin II, the normal
aldosterone regulator. As a consequence, aldosterone synthesis becomes linked to
Cortisol synthesis that is normally -1,000 fold higher, and maintenance of normal
Cortisol levels results in constitutively excessive aldosterone secretion and
hypertension.
1.2.6.1.2 Defective Aldosterone Synthesis
Conversely, mutations resulting in loss of aldosterone synthase activity lead to
impaired aldosterone biosynthesis. Individuals bearing two defective gene copies of
aldosterone synthase have a mirror image of the GRA phenotype, with severely
impaired renal salt retention in the distal nephron and hypotension (Mitsuuchi et al.,
1992; Pascoe et al., 1992).
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1.2.6.2 MR
1.2.6.2.1 Hypertension Exacerbated in Pregnancy
A mutation in the ligand binding domain of the mineralocorticoid receptor (MRS810L)
causes an autosomal dominant form of hypertension that is markedly accelerated in
pregnancy (Geller et ah, 2000). Compounds that normally bind, but do not activate
MR are all potent agonists of the mutant receptor. This includes steroids lacking 21-
hydroxyl groups, such as progesterone, and clinically used antagonists ofMR, such as
spironolactone. Since progesterone levels rise 100-fold during pregnancy, this
observation suggested that patients harboring MR-L810 might develop severe
hypertension in pregnancy. Indeed, all pregnancies among patients harboring this
mutation have been complicated by dramatic acceleration of hypertension associated
with complete suppression of the renin-angiotensin system (Geller et ah, 2000).
1.2.6.2.2 Autosomal Dominant PHA1
Pseudohypoaldosteronism type I (PHAI) features severe neonatal salt wasting with
hypotension despite markedly elevated aldosterone levels. Patients with the dominant
form have heterozygous loss-of-function mutations in MR, with a variety of
premature termination and frameshift mutations identified in affected kindreds (Geller
et ah, 1998). This partial loss of MR function impairs maximal salt reabsorption.
These findings indicate that two normal copies of MR are required for normal salt
homeostasis in the neonatal period. However, upon assumption of a normal salt-rich
diet, these patients typically become entirely asymptomatic and show no obvious
phenotypic consequence (Geller et ah, 1998).
21
1.2.6.3 11/3-HSD2
1.2.6.3.1 Syndrome ofApparent Mineralocorticoid Excess (AME)
This autosomal recessive disease features early onset hypertension with hypokalemia
and metabolic alkalosis accompanied by suppressed plasma renin activity and the
virtual absence of circulating aldosterone. Affected individuals showed impaired
conversion of Cortisol to cortisone due to absence of the enzyme 11 P-hydroxysteroid
dehydrogenase type 2 (llpHSD-2; Ulick et al., 1979). The homozygous loss-of-
function mutations of lipHSD-2 in AME patients allow Cortisol to activate MR,
resulting in hypertension mediated by increased ENaC activity (Mune et al., 1995).
1.2.6.4 ENaC
1.2.6.4.1 Autosomal Recessive PHAI
Loss-of-function mutations in any of the three different ENaC subunits cause the
autosomal recessive form of PHAI (Chang et al., 1996; Strautnieks et al., 1996). Like
dominant PHAI, the recessive form features severe salt wasting and hypotension in
the neonatal period despite high levels of aldosterone. In addition to these effects on
renal salt handling, mutations in ENaC impair the clearance of fluid from the surface
epithelium of the lung in humans and mice. Indeed, mice with targeted knock-out of
ENaC subunits have the PHAI phenotype and, in addition, have respiratory failure
due to impaired clearance of lung water (Hummler et al., 1996; Barker et al., 1998).
1.2.6.4.2 Liddle Syndrome
Liddle syndrome is characterized by autosomal dominant phenotype of early onset
hypertension associated with suppressed plasma renin activity, and low plasma
aldosterone levels. This disease is caused by mutations in either the p or the y subunit
of ENaC that truncate their cytoplasmic C termini (Shimkets et al., 1994; Hansson et
al., 1995a), or missense mutations in a segment in the C terminus of the P or the y
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subunit, bearing a PPPXY amino acid motif (Hansson et al., 1995b; Inoue et al.,
1998). These deletions or mutations yield an increase in the number of functional
channels at the cell surface (Snyder et al., 1995; Schild et al., 1996). Two lines of
evidence have suggested mechanisms for the reduced clearance ofmutant ENaC from
the cell surface. Inhibition of endocytosis via clathrin-coated pits induces an increase
in Na current by markedly prolonging the half life of ENaC at the cell surface
(Shimkets et al., 1997). In parallel, two WW domain-containing proteins, Nedd4-1
(Staub et al., 1996) and Nedd4-2 (Kamynina et al., 2001) have been identified that
specifically interact with the PPPXY sequence of ENaC subunits. These proteins have
ubiquitin ligase domains and target ENaC for degradation by ubiquitination.
Expression of modified forms ofXenopus Nedd4 (Abriel et al., 1999) or mammalian
Nedd4-2 (Kamynina et al., 2001), containing the WW domain without the ubiquitin
ligase domain, also prolongs the half-life of wild-type ENaC by impairing the
retrieval of ENaC for degradation.
1.2.7 Research Models for Studying Aldosterone Action in vitro and
in vivo
1.2.7.1 In vitro cell culture
Cell culture systems have been very useful in characterizing the aldosterone response
in vitro. Handler et al (1979) established cell lines from the Xenopus laevis kidney
(A6). This epithelial cell line has been frequently used to characterize the response of
sodium reabsorption to corticosteroids via GR (little or no MR is expressed in this cell
line) both qualitatively and quantitatively. A mouse cortical collecting duct (CCD)
cell line (M-l), reported in Stoos BA et al (1991), requires dexamethasone, a synthetic
glucocorticoid, to establish a transepithelial Na transport but is not directly sensitive
to aldosterone. A rat CCD cell line was established by Blot-Chabaud et al (1996).
Nevertheless, it does not appear to respond to aldosterone either. A novel mouse CCD
cell line (mpkCCD) generated by Bens et al (1999) displays a high level of sodium
transport that can be upregulated by high aldosterone concentrations. However, whilst
M-l cells are available via national tissue culture collection facilities, mpkCCD cells
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are not yet.
1.2.7.2 Normal (wild-type) and genetically modified animals
The effects of aldosterone on ion transport have been extensively studied in vivo in a
variety of animal species, including rats, rabbits, mouse, dogs and humans. Plasma
level of aldosterone in these animals can be varied by aldosterone injections,
aldosterone infusion or by a range of other means such as changing the Na or K intake.
These research models are very useful in elucidating the overall physiological
response to aldosterone. The feasibility of generating genetically modified animals
has enabled study of the effects of specific molecular components of the aldosterone
pathway in vivo. Eight mouse models relevant to aldosterone action and the control of
blood pressure are summarized below.
1.2.7.2.1 MR''mice and GR~~ mice
Mice in which the MR was knocked out developed severe symptoms of
pseudohypoaldosteronism with failure to thrive, weight loss, severe Na and water loss,
and a highly stimulated renin-angiotensin system (Berger S et al. 1998). These mice
develop normally in utero but die 8-12 days after birth from
pseudohypoaldosteronism. Although the amiloride-sensitive Na+ reabsorption was
reduced, the mRNA level of ENaC and Na+/K+-ATPase was not changed in the
kidney, indicating even the maintenance of basal levels of Na reabsorption sufficient
to allow survival was apparently not achieved by such MR independent
transcriptional control of the amount of ENaC and Na+/K+-ATPase. Mice rescued by a
subcutaneous injection of sodium chloride during the critical phase survive and
develop normally, compensating a persisting loss of salt by an increased uptake and a
chronically upregulated renin-angiotensin system (Bleich M et al. 1999). Daily
injections of the glucocorticoid betamethasone from day 5 after birth prolonged the
survival of MR7" mice, but failed to completely replace the MR function. Knocking
out GR in vivo resulted in perinatal death due to respiratory failure and severely
retarded lung maturation. ENaC mRNA was markedly downregulated in lung in these
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GR7" mice (Cole TJ et al. 1995).
1.2.7.2.2 llfUISDl'-
Apparent mineralocorticoid excess is characterized by the lack of 11 (3-HSD2, an
enzyme which prevents glucocorticoids from occupying and activating co-localized
mineralocorticoid receptors. As expected, 11P-HSD2 null mice display hypertension,
hypokalemia and show striking hypertrophy and hyperplasia of the distal nephron
(Kotelevtsev Y et al. 1999).
1.2.7.2.3 Genetically engineered mouse models to study ENaCfunction
A series of ENaC subunit-defective mice and a mouse model expressing a hyperactive
channel corresponding to that found in Liddle's syndroms have been generated over
the past few years (Hummler E et al. 1996-1997; Barker et al. 1998. McDonald F et al.
1999; Pradervand S et al. 1999(a,b)). A major conclusion of these studies is that all
three ENaC subunits are necessary for normal neonatal lung liquid clearance and also
for the function of the kidney ASDN.
Knocking-out the mouse aENaC gene locus (aENaC7") led to respiratory
complications and neonatal death, thus indicating the crucial role of aENaC in lung
liquid clearance at birth. The amiloride-sensitive electrogenic Na transport in airway
epithelia was abolished (Hummler E et al. 1996). Expressing the aENaC subunit in
the aENaC knockout mice under the control of cytomegalovirus promoter rescued the
aENaC knockout mice from this fatal neonatal lung disorder (Hummler E et al. 1997).
Although these rescued mice had sufficient basal Na reabsorption to clear the liquid in
lung and survived the early neonatal period, they developed a phenotype similar to the
pseudohypoaldosteronism type I (PHA-I) with renal salt-wasting despite high plasma
aldosterone levels.
Disruption of the beta subunit of ENaC in mice resulted in similar salt wasting,
hyperkalemia and neonatal death associated with a pseudohypoaldosteronism
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phenotype (McDonald F et al. 1999). Mice bearing a mutation in the mouse PENaC
gene locus (PENaCm/m) had pENaC protein deficiency (Pradervand S et al. 1999a). On
a regular salt diet (0.3% Na), these pENaCm/m mice exhibited a mild PHA-I phenotype
but developed an acute PE1A-I when challenged with a low salt (0.01% Na) diet.
Knock-out of the yENaC subunit in mice resulted in early death (36h after birth) of
animals probably due to disturbed circulatory and electrolyte balance, relating to renal
salt wasting PHA-I phenotype (Barker PM et al. 1998).
An interesting 'ENaC dosage' experiment was performed by replacing the carboxy-
terminus of the wild-type P subunit with that of a 'Liddle mutation'. These mice
developed a salt-sensitive hypertension with hypokalemic alkalosis typical of
Liddle's syndrome (Pradervand S et al. 1999b).
1.3 THE EPITHELIAL SODIUM CHANNEL (ENAC)
A major breakthrough in understanding sodium regulation in distal nephron came
with the cloning of the subunits of the amiloride-sensitive epithelial sodium channel
(ENaC) (Canessa CM et al 1993, 1994). ENaC is expressed primarily in polarized
epithelia in the distal nephron, lung, distal colon, and other organs (Garty H et al
1997).
1.3.1 Structure
ENaC is composed of three related subunits, a, P and y (Canessa CM et al 1993, 1994;
Lingueglia E et al 1993; McDonald FJ et al 1994, 1995; Voilley N et al 1995),
arranged in a stoichiometry of 2a:ip:ly (Firsov D et al 1998; Kosari F et al 1998).
Expression of all three ENaC subunits is needed for full channel activity, although
expression of the a-subunit alone or aP- or ay-subunit combinations leads to the
generation of small currents as well (Canessa CM et al 1993, 1994; Firsov D et al
1996). Every subunit consists of two transmembrane domains (Ml, M2), a long
extracellular loop and the intracellular N/C-termini (Figure 1.7). The C-termini of all
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Epithelial sodium channel ( ENaC)
Figure 1.7. Structure and stoichiometry ofENaC.
subunits contain two proline-rich consensus sequences PY (PPPnY) (Schild L et al.
1996). Premature truncation of the C-terminus in either P or y subunit results in both
an increased channel open probability (P0) and decreased channel retrieval rate from
the apical membrane (Schild L et al. 1995; Snyder PM et al. 1995). The deletion of p
or y N-terminals dramatically alteres single channel values ofmean open/close time (x)
and reduces ENaC-mediated sodium conductance. The N-terminal of a subunit (1-
109) contains two distinct motifs. Truncation of amino acids 2-67 increases the
number of active channels in the apical membrane whereas deletion of the entire N-
terminal abolishes ENaC sodium currents (Chalfant ML et al. 1999). The large
extracellular loop of about 500 amino acids includes the amiloride-binding sites,
several glycosylation sites and a cysteine-rich domain, using which subunits are
connected by disulfide bonds (Snyder PM et all994).
1.3.2 Topology
Hydropathy plot analysis indicates that all ENaC subunits have two hydrophobic
regions separated by a large (-500 amino acids) hydrophilic loop. Three independent
studies have determined the membrane topology of the rat aENaC subunit (Synder
PM et al 1994; Canessa CM et al 1994(a); Renard SE et al 1994). In vitro translation
of aENaC produced a 73kDa protein and an additional 93kDa protein corresponding
to the glycosylated form. The aENaC subunit contains eight potential sites for N-
linked glycosylation, among which mutation of six sites (Asn 190-538) abolished the
glycosylation of aENaC, suggesting the six sites are localized to the extracellular side
of the plasma membrane. To localize the N or C-terminus with respect to the plasma
membrane, Synder et al (1994) placed a Flag epitope at the terminus and determined
the sensitivity of the epitope to proteinase K. Both the N and C-terminal epitopes
were not protected from the protease digestion, indicating that they are oriented on the
intracellular side of the plasma membrane. Topological analysis of the p and y
subunits have not been reported so far, but it is likely to be the same as aENaC. The
fact that >60% of the amino acids in aENaC face the extracellular domain is
somewhat surprising. Such a structure might be thought to be important for
interaction with large molecules that cannot diffuse close enough to the membrane
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surface. This is not likely to be the case for Na ion. The N-terminus of ENaC subunits
plays a role in subunit-subunit interactions (Adams et al 1997) whereas the C-
terminus functions in the regulation of ENaC, at least in part by mediating the
ubiquitination of ENaC and its endocytosis.
1.3.3 ENaC Trafficking to Cell Surface
In recent years, several groups have focused their studies on characterizing ENaC
processing and trafficking, primarily in A6 cells and in cells that express ENaC
heterologously [e.g. X. laevis oocytes, COS cells, HEK-293 cells, and Madin-Darby
canine kidney (MDCK) epithelial cells]. In general, it appears that ENaC processing
is inefficient, with -1% of channels synthesized in the endoplasmic reticulum (ER)
making it to the cell surface when they are expressed in X. laevis oocytes (Valentijn
JA et al 1998) and an estimated -20% in A6 cells, which express X. laevis ENaC
fxENaC) endogenously (Weisz OA et al 2000). Moreover, the presence of ENaC at
the cell surface is almost undetectable in renal tight epithelia that are not stimulated
by aldosterone. Thus virtually no channel activity is observed in cortical collecting
ducts from rats with low plasma aldosterone levels (Pacha J et al 1993), and ENaC
subunits cannot be detected at the apical membrane of the distal nephron by
immunohistochemistry under similar conditions (Loffing J et al 2000, 2001;
Masilamani S et al 1999). An important determinant of the efficiency of ENaC
maturation is the assembly of its subunits in the ER. ENaC assembly likely occurs
very early during its processing in the ER, as suggested by co-immunoprecipitation
experiments that demonstrate association of ENaC subunits in both glycosylated and
unglycosylated forms (Adams CM et al 1997). Although biochemical (Adams CM et
al 1997; Cheng C et al 1998; Firsov D et al 1996) and functional (Canessa CM et al
1994; Ishikawa T et al 1998) data have demonstrated that the expression of the a-
subunit alone, or a combination of a(3- or ay-subunits, can lead to the appearance of
functional channels at the cell surface, the efficiency of maturation of such "partial"
channels is extremely low. This coincides with enhanced ubiquitination and
proteasomal degradation of ENaC subunits when expressed individually (Staub O et
al 1997; Valentijn JA et al 1998). Moreover, although ectopic expression of the a-
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subunit leads to exclusive lactacystin-sensitive (proteasomal) degradation, expression
of all three ENaC subunits results in the appearance of an ENaC pool that is sensitive
to lysosomal inhibitors (Staub O et al 1997).
1.3.4 Glycosylation
A useful tool in studying maturation and trafficking of transmembrane proteins from
the ER to the Golgi is to trace their Asn (N)-linked glycosylation pattern. In the ER,
transmembrane proteins acquire core glycosylation, which is sensitive to peptide N-
glycosidase-F (PNGaseF). This core glycosylation is then trimmed at the ER and, on
transport to the Golgi apparatus, is replaced with complex glycosylation that is
resistant to endoglycosidase H (Endo-H). The Endo-H-resistant pool is often used as a
marker to follow the mature transmembrane protein. However, one of the major
difficulties in studying ENaC trafficking and maturation is the apparent lack of a
detectable Endo-H-resistant pool of this channel (Canessa CM et al 1994(a); Renard S
et al 1994; Snyder PM et al 1994; Valentijn JA et al 1998; Hanwell D et al 2002). The
lack of a detectable Endo-H-resistant pool of cellular ENaC has suggested that either
this channel does not acquire complex glycosylation or that the very small fraction of
ENaC that actually translocates to the cell surface has complex glycosylation but is
below the detection limits. Hanwell D et al (2002) have demonstrated that the surface
pool of ENaC is glycosylated in a pattern similar to that for the ER pool and exhibits
PNGaseF and Endo-H sensitivity, suggestive that an immature pattern of
glycosylation persists in ENaC during its trafficking to the cell surface. The role of
glycosylation of transmembrane proteins has received great attention, and it appears
that in some cases it is involved in apical targeting, whereas in others it does not
appear to be so (Yeaman C et al 1999). The role of ENaC glycosylation in ENaC
trafficking is presently obscure. All three ENaC subunits possess numerous potential
N-linked glycosylation sites at their ectodomains (Canessa CM et al 1994(a)).
Mutating some or all of the glycosylation sites does not seem to affect channel
activity (Canessa CM et al 1994(a); Snyder PM et al 1994), suggesting that sugar
modification of ENaC does not affect proper trafficking to and insertion of the
channel in the plasma membrane.
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1.3.5 Solubility in Nonionic Detergent
Recent work in COS and HEK-293 cells heterologously expressing ENaC has shown
that the channel is transformed during its processing from a nonionic detergent (Triton
X-100)-soluble form in the ER to a Triton X-100-insoluble form during trafficking to
the cell surface (Prince LS et al 1998, 1999). The acquisition of such nonionic
detergent insolubility is often proposed to be mediated by an association with 'lipid
rafts'. Lipid rafts are cholesterol- and sphingolipid-rich microdomains within
membranes often associated with (mainly apical) targeting of proteins sequestered in
such rafts (Simons K et al 1997). However a recent study shows that ENaC expressed
in MDCK cells is not associated with lipid rafts (Hanwell D et al 2002). Thus, it
appears that ENaC is not utilizing lipid rafts to traffic to the cell surface, at least in
such cells.
1.3.6 ENaC Association with Cytoskeleton
Several reports have proposed interactions between ENaC and cytoskeletal proteins,
including a-spectrin (Rotin D et al 1994; Zuckerman JB et al 1999) and actin (Berdiev
BK et al 1996; Jovov B et al 1999). Although it appears likely that cytoskeletal
interactions are involved in stabilizing ENaC at the cell surface and possibly in
regulating its activity, it is not known what precise role such interaction may play.
1.3.7 Endocytosis of ENaC
Nedd4, a ubiquitin protein ligase, plays a key role in endocytosis of ENaC. The
binding of Nedd4 with the PY domains of ENaC P and y subunits facilitates the
ubiquitination at lysine residues of ENaC a and y N-terminals (Staub O et al. 1996,
1997). Degradation of ubiquitinated proteins is carried out by 26S proteasomes or
lysosomes. As for ENaC degradation, the unassembled subunits are targeted to the
26S proteasome whereas the assembled aPy complex is directed to the lysosome by
clathrin-mediated endocytosis (Staub O et al. 1997). The half-life of (heterologously
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expressed) ENaC at the cell surface of X. laevis oocytes was reported to be ~2-3.5 h
(Shimkets RA et al 1997; Staub O et al 1997). In mammalian MDCK cells, this value
is lower -1-2 h (Hanwell D et al 2002), which is reasonable considering the higher
temperature in which these cells are grown relative to that for X. laevis oocytes. A
recent study using A6 cells has proposed a much longer half-life of xENaC and
suggested that cell surface stability of a- and y-ENaC (at least 24 h) is much greater
than that of (3-ENaC (6 h) (Weisz OA et al 2000). The turnover of ENaC is inhibited
in the context of (3- or y-ENaC subunit bearing Liddle's syndrome mutations in the PY
domain that abrogate the Nedd4 binding, resulting in several-fold increased half-life
of the channel in the plasma membrane (Firsov D et al 1996; Schild L et al 1996;
Shimkets RA et al 1997; Snyder PM et al 1995).
1.3.8 Regulatory Hormones
1.3.8.1 Aldosterone
Patch-clamp experiments in rat renal cortical collecting ducts (CCD) have indicated
that variations in plasma aldosterone levels, induced by changes in dietary salt intake,
modify the abundance of active ENaC in the apical plasma membrane (Pacha J et al
1993). No apical channel activity can be detected in animals that had low plasma
aldosterone and were fed a high-salt diet, whereas increasing plasma aldosterone
levels by restriction of Na intake dramatically increases the number of functional
apical channels. The physiological relevance of this regulation has been quantitatively
assessed recently by measurements of amiloride-sensitive Na currents recorded in
CCD cells of rats that were subjected to short-term salt deprivation and also had their
urinary Na excretion measured (Frindt G et al 2001). This study has shown that the
increase in ENaC current in response to a two- to threefold increase in plasma
aldosterone levels can account for reduced Na excretion under these conditions. In
situ immunohistochemical studies in mouse kidney have clearly showed that changes
in plasma levels of aldosterone affect the intracellular distribution of ENaC subunits
(Loffing J et al 2000; Masilamani S et al 1999). An increase in plasma aldosterone
level associated with dietary salt restriction causes a large increase in abundance of a-
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ENaC and a redistribution of ENaC subunits from the cytoplasm to the apical
membrane. The stimulation of a-ENaC expression and its shift from a cytoplasmic to
an apical membrane pool in the distal nephron can be observed as early as 2 h after
aldosterone injection (Loffing J et al 2001). The molecular and cellular mechanisms
underlying these effects remain to be elucidated. Besides the increase in a-ENaC
mRNA levels, aldosterone induces or represses the synthesis ofmany other transcripts
in principal cells of the distal nephron (Chapter aldosterone-induced proteins). These
aldosterone-induced proteins are likely to play an important role in ENaC regulation.
1.3.8.2 Vasopressin
Vasopressin (antidiuretic hormone; ADH) increases ENaC conductivity in a variety of
sodium-transporting epithelia (Ausiello DA et al. 1987; Schafer JA and Hawk CT.
1992; Eaton D et al. 1995). The effect of AVP is mediated via AVP binding to its V2
receptors, leading to the stimulation of adenylate cyclase and a concomitant increase
in the level of intracellular cAMP. A number of observations suggest that such a
cAMP stimulated pathway acts by translocating ENaC from a cytoplasmic pool into
the apical membrane (Erlij D et al 1999; Kleyman TR et al 1994; Blazer-Yost BL et al
2001). Stimulation of ENaC expression at the cell surface by vasopressin seems
different from that of aldosterone because the effects of the two hormones are
synergistic (Breyer MD and Ando Y 1994).
1.3.8.3 Insulin
Insulin evokes a -50% upregulation of amiloride-sensitive sodium transport across
frog skin (Civan MM et al. 1988, 1989), toad bladder (Blazer-Yost B et al. 1988, 1989)
and A6 cells (Erlij D et al. 1994; Marunaka Y et al. 1992; Record R et al. 1998). In
frog skin, the increase in Na conductance was accompanied by a parallel increase in
the apical electrical capacitance, suggesting that the hormone promotes an exocytic
delivery of channels to the apical membrane (Civan MM et al. 1988, 1989). On the
other hand, studies in A6 cells using patch clamping have shown effects of insulin on
channel open probability but not on the number of channels per patch (Marunaka Y et
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al. 1992). The precise mechanism mediating the insulin response is yet to be
elucidated though phosphatidylinositol 3-kinase activation was required for insulin-
stimulated sodium transport in A6 cells (Record R et al. 1998).
1.3.9 Regulatory Proteins
A few proteins have been shown to interact with ENaC and regulate its activity.
Among them, sgkl, capl and syntaxin 3 increase ENaC mediated sodium transport
whereas Nedd4 and syntaxin 1A reverse the process. These appear to act by very
different mechanisms (discussed next in detail).
1.3.9.1 Kinases
Although it is well known that cAMP activates amiloride-sensitive sodium transport
in rat and Xenopus renal epithelia (Ausiello DA et al. 1987; Schafer JA and Hawk CT
1992; Eaton D et al. 1995), disparate observations were reported on the stimulation of
ENaC by cAMP or PKA (protein kinase A) when the channel was incoiporated into
artificial lipid bilayers or coexpressed in Xenopus oocytes (Lester DS et al. 1988;
Awayda MS et al. 1996). PKC (protein kinase C) was shown to cause a direct
reduction of channel open probability in the oocyte expression system (Awayda MS et
al. 1996; Oh YS et al. 1997). Both PKA and PKC increase the phosphorylation of the
(3 and y subunits of ENaC in Xenopus oocytes (Shimkets RA et al. 1998). A recently
identified serine/threonine kinase, sgkl (Chen SY et al. 1999) stimulates ENaC
translocation to the cell membrane of Xenopus oocytes (De la Rosa D et al. 1999).
Pearce and colleagues have demonstrated its in vitro binding to the C-termini of
ENaC a or (3 subunits (Wang J et al. 2001). Nevertheless, the phosphorylation of
ENaC P and y C-terminals was not mediated via sgkl (Wang J et al. 2001), although
stimulation of ENaC did require sgkl kinase activity (Loffing J et al. 2001).
1.3.9.2 Proteases
In Xenopus oocytes injected with ENaC cRNA, addition of exogenous trypsin or
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chymotiypsin to media (Chraibi A et al. 1998), or expression of the protease CAP-1
(channel activating protease, Vallet V et al. 1997), increases the conductivity of ENaC.
Incubation with serine protease inhibitor-aprotinin abolishes this effect, suggesting the
involvement of a proteolytic pathway (Vallet V et al. 1997). Careful studies using the
cell-attached patch-clamp mode indicate that the protease effect is a 'local'
phenomenon, i.e. a mechanism that involves protein(s) which are bound or adjacent to
the channel within the lum of membrane area included in a pipette patch and that
does not include signal transduction through second messengers remotely from such
cell patches (Chraibi A et al. 1998). The inhibitory effect of aprotinin and subsequent
restoration by protease were also observed in mammalian cells (Nakhoul N et al.
1998), suggesting the presence of a conserved proteolytic pathway regulating ENaC
conductance. No evidence has yet been found supporting the direct cleavage of ENaC
subunits.
1.3.9.3 SNARE
The specificity of docking and fusion of vesicles with plasma or organelle membranes
is mediated by specialized membrane proteins present in vesicles and target
membranes, named v-SNARE or t-SNARE respectively (McNew JA et al. 2000;
Parlati F et al. 2000). The interaction between v and t-SNAREs requires SNAPs
(soluble N-ethylmaleimide-sensitive-factor attachment protein). In kidney cells,
syntaxin 1A (t-SNARE) is localized to the basolateral membrane and co-precipitates
with ENaC y subunits. When co-expressed with ENaC in Xenopus oocytes, syntaxin
1A inhibits ENaC conductance (Qi J et al. 1999). In contrast, syntaxin 3 (t-SNARE)
stimulates ENaC mediated Na transport in Xenopus oocytes and is localized to the
apical membrane of renal cells (Saxena S et al. 1999).
1.3.9.4 Nedd4 isoforms
Nedd4, originally cloned as a gene that is developmentally down-regulated in mouse
brain (Kumar S et al 1992), represents the prototype for a larger protein family, the
emerging Nedd4/ Nedd4-like family of ubiquitin-protein ligases (Rotin D et al 2000;
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Harvey KF and Kumar S 1999). Members of the Nedd4/Nedd4-like family possess a
similar molecular organization: two to fourWW (protein-protein interaction) domains,
a C-terminal HECT (homologous to E6-AP-carboxy-terminal ubiquitin-protein ligase)
domain and many having an N-terminal C2 (Ca2+ dependent lipid binding) domain.
Two isoforms of Nedd4 have been identified in mice (Kamynina E et al 2001).
Whereas mNedd4-l contains a C2 domain, three WW domains and a HECT domain,
mNedd4-2 contains four WW domains and a HECT domain, yet lacks a C2 domain.
In Xenopus, one isoform has been cloned (Staub O et al 1996), containing a C2
domain, four WW domains and a HECT domain and showing higher homology to
mNedd4-2. The third and fourth WW domains of xNedd4 and mNedd4-2 are protein-
protein interaction modules that bind the proline-rich PY motif (xPPxY) in the C-
terminus of P- or y-subunit of ENaC (Staub O et al 1996; Kamynina E et al 2001).
Several recent reports have demonstrated that xNedd4 or mNedd4-2 is a repressor of
ENaC that regulates the endocytosis of channels from the cell surface (Abriel H et al
1999; Farr TJ et al 2000; Staub O et al 1997; Harvey KF et al 1999; Kamynina E et al
2001). This function of Nedd4 requires the presence of intact PY motifs, to which the
Nedd4-WW domains bind. Snyder et al (1995) and Schild et al (1996) have
demonstrated that mutations of the prolines and tyrosine of the PY motif lead to
elevation of ENaC activity. Moreover, repression by Nedd4 also required its HECT
domain to be active, indicating that ENaC ubiquitination is involved (Abriel H et al
1999). Ubiquitination of ENaC was previously demonstrated to regulate its cell
surface stability, and mutation (to arginine) of key conserved lysine residues (where
ubiquitination occurs) located at the NH2 termini of a- and y-ENaC leads to both
impaired channel ubiquitination and increased stability of the channel at the plasma
membrane (Staub O et al 1997).
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1.4 Research Aims
1, to examine sgkl gene expression in kidney and its regulation by aldosterone (e.g.
dose response, cellular localization and time course);
2, to identify and characterize other novel aldosterone induced genes in the kidney;
3, to characterize corticosteroid modulation of ENaC trafficking in mouse collecting
duct cells (e.g. dissecting the subcellular events underpinning ENaC trafficking and its
hormonal regulation);
4, to elucidate the role of sgkl in modulating ENaC conductance and to generate a
cell model in which the expression of sgkl can be tightly regulated by the tetracycline
inducible system. This model can become available and widely accessible to
determine whether upregulation of sgkl by tetracycline influences ENaC-mediated
sodium reabsorption in parallel to that by corticosteroids.
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CHAPTER 2 MATERIALS AND METHODS
2.1 Material
2.1.1 Chemicals
All chemicals were obtained from BDH Chemicals Ltd (Magna Park, Lutterworth,
Leicestershire LEI7 4XN) or Sigma Chemicals Ltd (Fancy Road Poole, Dorset, BH17
7NH) unless otherwise stated.
Agarose Invitrogen (Renfrew Road, Paisley PA3 4EF)
Bactotryptone Beckton Dickinson (Towns Road, Oxford 0X4 3LY)
Caesium Chloride Invitrogen (Renfrew Road, Paisley PA3 4EF)
D19 developer H.A. West Ltd (41 Watson Cresent, Edinburgh EH11 1ES)
Ethanol Hayrnan Ltd (70 Eastways Industrial Witham, Essex CMS 3YE)
G418 (geneticin) Invitrogen (Renfrew Road, Paisley PA3 4EF)
Hygromycin B BD Clontech (1020 East Meadow Circle, Palo Alto, CA, USA)
Nucleotide Amersham Pharmacia Biotech UK Ltd (Little Chalfont,
triphosphates Bucks HP7 9NA)
Proteinase K Boehringer Mannheim UK (Bell Lane, Lewes BNY 1LG)
Puromycin BD Clontech (1020 East Meadow Circle, Palo Alto, CA, USA)
Tetracycline BD Clontech (1020 East Meadow Circle, Palo Alto, CA, USA)
Yeast extract Beckton Dickinson (Towns Road, Oxford OX4 3LY)
Yeast tRNA Invitrogen (Renfrew Road, Paisley PA3 4EF)
2.1.2 Radiochemicals
All radiochemicals were supplied by Amersham Pharmacia Biotech UK Ltd (Little










AlexFluor 660 tagged goat anti-mouse
secondary antibody (#A21054)
MitoTracker (#M22426)
rhodamine-B hexyl ester (#R648)
rhodamine-conjugated








All restriction enzymes (except stated), DNasel, Taq DNA polymerase, T7 DNA
polymerase, T4 DNA polymerase, AMV reverse transcriptase and T4 DNA ligase





New England Biolabs Ltd
(73 Knowl Piece, Hertfordshire SG4 OTY)
New England Biolabs Ltd
(73 Knowl Piece, Hertfordshire SG4 OTY)
Statagene Ltd
(North Torrey Pines Road, La Jolla, CA, US)
Sigma Chemicals










(Chilworth Research Center, Southampton
SO 16 7NS)
BD Clontech













(1020 East Meadow Circle, Palo Alto, CA, USA)
Gift ofDr Rory Duncan (Dept of Biomedical
Sciences, University of Edinburgh)
Roche Molecular Biochemcials (Sandhofer
Strasse 116, D 68305 Mannheim, Germany)
2.1.7 Cell Culture Reagents
All media and additives for maintenance of cell lines were supplied by Invitrogen
(Renfrew Road, Paisley PA3 4EF).
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Figure 2.2. Map of the plasmid pEYFP-Cl.
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Figure 2.3. Map of the plasmid pHcRedl-Cl.
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Figure 2.4. Map of the plasmid pTRE2hyg.
Penicillin/Streptomycin (lOOOOU/ml; 1 OOOOpg/ml)
Trypsin/EDTA (10x)
2.1.1 Cells andAnimals
2.1.8.1 Bacteria strainsfor cloning
The E.coli strain HB101 was supplied by Promega Ltd (Chilworth Research Center,
Southampton SO 16 7NS).
2.1.8.2 Cell lines
The mouse collecting duct M-l cell line was purchased from the European Cell Line
Collection.
2.1.8.3 Animals
Animals were supplied by Charles River Ltd (Margate Kent, UK)
2.1.9 Miscellaneous




Dried skimmed milk powder
ECL (peroxidase-based
BioRad Laboratories Ltd. UK
Becton Dickinson
(2350 Qume Drive, San Jose, CA, US)
Bright Instruments Ltd. UK
(Maylands Avenue, Hernel Hampstead HP2 7TD)
Invitrogen
(Renfrew Road, Paisley PA3 4EF)
Marvel
(Premier Beverages, Stafford SR20 OQJ)
Amersham Pharmacia Biotech UK Ltd









NICK column (Sephadex G50)
Oligonucleotides
Pico-fluor 40 scintillant fluid












Zeiss confocal LSM microscope
Becton Dickinson
(2350 Qume Drive, San Jose, CA, US)
Invitrogen
(Renfrew Road, Paisley PA3 4EF)
DPC (Los Angeles, CA, US)
Whatman Labsales Ltd. UK
Amersham Pharmacia Biotech UK Ltd
(Little Chalfont, Bucks HP7 9NA)
BDH [Merck Ltd.] UK
Amersham Pharmacia Biotech UK
(Little Chalfont, Bucks HP7 9NA)
Invitrogen
(Renfrew Road, Paisley PA3 4EF)
Amersham Pharmacia Biotech UK Ltd
(Little Chalfont, Bucks HP7 9NA)
Qiagen UK (Boundary Court, Gatwick Road,
West Sussex RH10 9AX, UK)
Amersham Pharmacia Biotech UK Ltd
(Little Chalfont, Bucks HP7 9NA)
BDH (Magna Park, Lutterworth, Leicestershire
LE17 4XN)
Corning Costa (10 Valley Center, Gordon Road,
Bucks HP 13 6EQ)
Invitrogen
(Renfrew Road, Paisley PA3 4EF)
Carl Zeiss UK





Zeiss LSM Image Brower Carl Zeiss UK
(v3.1)
2.1.10 General Buffers
Unless stated, the distilled water was used to prepare all buffers. All buffers were








MOPS electrophoresis buffer (lOx)
SDS lysis buffer
SDS running buffer (lOx)
1M Tris-HCl (pH8.0)
5M potassium acetate
0.2M NaOH, 1% SDS
0.5nrl DEPC was added to 500ml water
and kept at room temperature for lh before
autoclaving
0.25% (w/v) bromophenol blue, 0.25% (w/v)
cyanol, 30% glycerol
800ml water was added to 186.1 g EDTA. pH
was adjusted to 8.0 with NaOH and the volume
adjusted to 1000ml
34.03% bromophenol blue, 0.03% xylene cyanol,
20mM EDTA in deionized formamide
50mM glucose, 25mM Tris-HCl (pH 8.0),
lOrnM EDTA
0.2M MOPS (pH7), 20mM sodium acetate,
lOmM EDTA
150mM NaCl, 50 mM Tris, pH 7.4, 1% SDS,
0.5mM phenylmethylsulfonyl fluoride
0.25M Tris, 2.5M Glycine, 1% SDS
121. lg Tris was added to 800ml water. pH was
adjusted to 8.0 with concentrated HC1 and the
volume to 1000ml with water
245.6g potassium acetate was dissolved in
300ml water. The volume was adjusted to 500ml
by adding 57.5nrl glacial acetic acid and
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142.5ml water
TBE (lOx) 108g Tris, 55g boric acid, 20ml 0.5M EDTA
were made to 1000ml water
TE (lOx) lOmM Tris-HCl (pH8.0), ImM EDTA
2M sodium acetate (pH4.0) 272g sodium acetate was dissolved in 800ml
water. pH was adjusted to 4.0 with glacial acetic
acid and the volume to 1000ml
2.1.11 Molecular Biology Buffers
Restriction bufferA 90mM Tris-HCl, lOmM MgCl2, 50mM NaCl,
ImM DTT (pH7.5)
Restriction buffer B 6mM Tris-HCl, 6mM MgCl2, 150mM NaCl,
ImM DTT (pH7.9)
Restriction buffer C lOmM Tris-HCl, lOmM MgCl2, 150mM KC1
ImM DTT (pH7.4)
Restriction buffer D 6mM Tris-HCl, 6mM MgCl2, lOOmM NaCl,
ImM DTT (pH7.5)
Restriction buffer (Multi-Core) 500mM NaCl, 500mM Tris-HCl, 1 lOmM
MgC12, 60mM P-mercaptoethanol, lmg/ml
bovine serum albumin (pH8.0)
Transcription optimized buffer 40mM Tris-HCl (pH7.9), 6mM MgCl2, 2mM
spermidine, lOmMNaCl
T4 DNA ligase buffer 30mM Tris-HCl (pH7.8), 1 OmM MgCl2, 1 OmM
DTT, ImM ATP






Agarose gels were prepared by adding solid agarose to lxTBE at 0.8-2% (w/v)
followed by boiling in a microwave oven. Up to 50pg/ml of ethidium bromide was
added to the gel mixture. Once set the gel was submerged in lxTBE in a Horizon 58
electrophoresis tank and electrophoresed at 100-200V. DNA was visualized on a UV
transilluminator at 254nm. To purity DNA fragments, the low melting point (LMP)
agarose was used instead and allowed to set in the cold room. DNA was visualized on
the UV transilluminator at 365nm to prevent UV damage to DNA.
2.2.1.2 Denaturingpolyacrylamide gel electrophoresis
A standard glass-plate sandwich of electrophoresis apparatus was assembled
according to the manufacturer's instructions. The 10% separating gel solution was
prepared by mixing 5ml 30% acrylamide, 3.75ml Tris-SDS (pH8.8) with 6.25ml H2O
and 50pl 10% (w/v) ammonium persulfate and lOpl TEMED. The gel solution was
applied to the sandwich using a Pasteur pipet and covered with a layer of H2O. After
polymerization (30-60min) at room temperature, H2O was poured off and replaced
with the stacking gel containing a mixture of 0.65ml 30% acrylamide, 1.25ml Tris-
SDS (pH6.8), 3ml H2O, 25pl 10% ammomium persulfate and 5pl TEMED. An
electrophoresis lane comb was inserted. Once set the gel sandwich was attached to
buffer chambers according to manufacturer's instructions. These chambers were filled
with lx SDS electrophoresis running buffer and the gels were run at 10mA of constant
current until the tracking dye reached the bottom of the gel.
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2.2.2 Preparation ofTotal RNA
Total RNA was prepared from homogenized tissue using TRIzol as instructed by the
manufacturer. The concentration of RNA was measured as 40 x A260 x dilution
factor/1000 (pg/pl). The purity of RNA was checked by A260/A280. RNA samples
displaying A260/A280 values in the range of 1.7 to 2.0 can be regarded as highly pure.
The integrity and size distribution of total RNA was checked by formaldehyde-
denaturing agarose gel electrophoresis in MOPS solution and ethidium bromide
staining.
2.2.3 Reverse Transcription (RT)
A 20pl RT reaction contained the following: 2.6-2.9pg template RNA, lpl oligo(dT)
primer (5' GGAATTCTTTTTTTTTTTTTTTTTT 3'), 200U AMV reverse
transcriptase, lx first strand buffer, lOmM DTT, 0.5mM dNTPs (dATP, dGTP, dCTP,
dTTP) and H2O. The RNA template and the oligo(dT) primer were denatured together
for 10 minutes at 65°C and snap-cooled on ice. This step removed secondary
structures from the template enabling template :primer complex formation. The RT
reaction was carried out at 42°C for 70 minutes, lpl of RT product was used as a
template for subsequent PCR amplification.
2.2.4 Polymerase Chain Reaction (PCR)
A 50pl PCR reaction consisted of the following: 0.5pM primers, 0.2 111M dNTPs
(dATP, dGTP, dCTP, dTTP), lx DNA polymerase buffer, 2.5U DNA polymerase,
template DNA and H2O. The PCR programs follows: A. 95°C denaturation 2 minute
(1 cycle); 95°C denaturation 30 seconds, T°C annealing 30 seconds, 72°C elongation 2
minutes (30 cycles); 72°C elongation 10 minutes. The annealing temperature was
adjusted according to the primers used. PCR with the Pfu DNA polymerase was used
in preference to that with the Taq DNA polymerase when PCR required high fidelity
amplification and involved amplification of large (>1.5kb) products. For subsequent
in situ hybridization, flanking T3 and T7 phage polymerase consensus sites were
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included at the 5' end of PCR primers and the nested PCR was performed as described
previously (McDonald P et al 2000). 15pl of PCR product was run on an ethidium
bromide stained 1% agarose gel until sufficient separation of bands was observed, lkb
molecular weight markers were used.
2.2.5 Cloning ofDNA
2.2.5.1 DNA digestion/ligation
Plasmid DNA or PCR product was digested using 5-15U of restriction endonuclease
in lx appropriate restriction buffer in a final volume of 10-40pi at 37°C for 2-5 hours.
DNA fragments (approximately 50ng) were ligated to vectors (approximately lOOng)
using 1-5U of T4 DNA ligase in lx ligase buffer in a final volume of lOpl at 14°C
overnight.
2.2.5.2 Preparation ofcompetent E. coli
For general cloning procedures, the recA HB101 strain was used. Transformation-
competent cells were prepared by inoculating in 1ml of Luria Broth (LB) a single
colony of FIB 101 and incubating in a rotator at 37°C overnight. 50ml of LB was then
inoculated with this 1ml culture and incubated at 37°C in a shaking bed for 2h so that
the cells were in the late log phase of proliferation. The culture was centrifuged in the
Beckman J2 centrifuge at 7000rpm for 5min and the pellet was resuspended in 20ml
of cold 0.1M CaCh. Cells were kept for lOrnin on ice and centrifuged again at
7000rpm for 5 min and resuspended in 2ml of cold CaCl2.
2.2.5.3 Transformation
To transform the competent HB101 cells, 200pl of cells were placed in a pre-chilled
1.5ml eppendorf tube on ice. 200-500ng of DNA was added to the cells and kept on
ice for 15min. The cells were then heat shocked for lrnin at 42°C and kept on ice for a
few minutes to recover. The entire content of the tube was then plated on a LB agar
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plate and incubated at 37°C overnight.
2.2.5.4 Minipreps
Following transformation, single transformant colonies were picked and used to seed
2ml of LB containing 100pg/ml ampicillin. After overnight incubation at 37 °C,
cultures were transferred into 1.5ml eppendorf tubes and centrifuged at 13,000rpm for
lmin and the pellet was resuspended in lOOpl GTE Lysis buffer. Next 200pl fresh
0.2M NaOH/l%SDS was added followed by 150pl 5M potassium acetate (pFI4.8).
The tubes were then centrifuged at 13,000rpm for 5min and the supernatant was
transferred to fresh eppendorf tubes and washed with 500pl
phenol/chloroform/isoamyl alcohol (25:24:1) and centrifuged. The supernatant was
precipitated with lml ethanol.
2.2.5.5 CsCl density gradient centrifugation
Single colonies of transformants containing the required plasmid were used to
inoculate 2ml LB containing lOOpg/ml ampicillin and grown for 8h at 37°C. The
culture was transferred to 500ml LB containing ampicillin and grown overnight at
37°C with shaking. Cells were pelleted at 6000rpm for 5min and the pellet was
resuspended in 12 GTE lysis buffer, followed by 24ml of fresh 0.2M NaOFI/l%SDS
and 16ml cold 5M potassium acetate. After centrifugation, the supernatant was
filtered through gauze and DNA was precipitated with 32ml isopropanol. The pellet
was air-dried and resuspended in 2.2nrl TE buffer to which 3g CsCl and 100f.il
ethidium bromide (lOmg/ml) were added. The DNA solution was transferred into a
3ml Beckman Quickseal tube, sealed and centrifuged for 4h at 100,000rpm. The
plasmid DNA band (formed in the middle of the tube) was removed using a syringe
and remixed with lg CsCl and lml TE buffer and re-centrifuged as before. Plasmid
DNA was extracted using isopropanol until no ethidium bromide color was observed.
Plasmid DNA was then dialyzed against 2L TE at 4°C.
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2.2.5.6 Construction ofexpression vector
The full-length cDNA encoding the mouse ENaCp subunit (20-2318bp, #AF112186)
was cloned from mouse kidney cDNA by polymerase chain reaction (PCR) using the
high-fidelity Pfu DNA polymerase. The expression vector for the EGFP-ENaCP was
generated by cloning the ENaCP PCR product into the Bglll/Sall sites of pEGFP-C2.
The full-length cDNA encoding the mouse sgkl (33-1675bp, #AF205855) was cloned
from mouse kidney cDNA by PCR using the Pfu DNA polymerase. The expression
vector for HcRed-sgkl was generated by cloning the sgkl PCR product into the
Bglll/Sall sites of HcRed-Cl. The coding region of HcRed was replaced with EYFP
using Agel/Bglll to generate the expression vector EYFP-sgkl. In addition, the region
encoding the fusion protein EYFP-sgkl was digested with Nhel/Sall and subcloned
into the vector pTRE2hyg to generate the expression vector TRE-EYFP-sgkl for the
usage in the tetracycline inducible system. The cloned ENaCP subunit and sgkl
inserts in the initial plasmids were sequenced fully confirming the absence of any
PCR mutation errors.
2.2.6 Cell Culture
Mouse cortical collecting ductM-l cells were grown at 37°C in a modified DMEM/F-
12 (1:1) supplemented with 100 U/ml penicillin, 100 mg/ml streptomycin, and 10%
fetal bovine serum (FBS: stripped twice with charcoal to remove endogenous steroids)
in a humidified incubator gassed with 5% CO2. For experiments with unpolarized M-
1 cells, the cells were sparsely seeded onto glass coverslips and incubated overnight
(i.e., 16-18 h). For experiments with polarized M-l cells, the cells were cultured on
6.5-mrn diameter, 0.4-pm pore size Transwell polycarbonate filters (Corning Costa
#3470) for at least 10 days to achieve high transepithelial resistance (>1,000 EFcm2).
Potential difference and transepithelial resistance were measured with Millicell-ERS.
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2.2.7 Transfection
Cells were seeded on 60mm dishes at the density of 5x10^ cells/ml 24h before
transfection. All solutions used were equilibrated to room temperature prior to use.
For each construct, 300pl solution was set up containing 37pl 2M CaCl2, 5pg DNA
and mixed with 300pl 2x HEPES-buffered saline with slow agitation and incubated at
room temperature for 20min. After brief vortexing, the DNA solution was added
slowly to the dishes of cells with agitation. 24h after transfection the medium in the
dish was changed and replaced with 3ml fresh medium.
2.2.8 Making ofStable Cell Lines
2.2.8.1 Titrating G418, Hygromycin, and Puromycin (Killing Curves)
Prior to using G418, hygromycin or puromycin to establish stable and double-stable
cell lines, it is important to titrate your selection agent stocks to determine the optimal
concentration for selection with the particular host cell line being tested. Around 2 x
105 cells were plated in each of six 10-cm tissue culture dishes containing 10 ml of the
appropriate complete medium plus vaiying amounts (0, 50, 100, 200, 400, 800 pg/ml)
of hygromycin or G418. Cells were incubated for 10-14 days, replacing the selective
medium every four days. For selecting stable transformants, the lowest concentration
of drug is used that begins to give massive cell death in ~5 days and kills all the cells
within two weeks.
2.2.8.2 Transfection and selection ofstable cell lines
Cells were transfected with EGFP-ENaCp construct at the density of SxlO^ cells/ml.
48 h after transfection, cells were trypsinized and seeded to medium in 10 plates
containing 500pg/ml G418. After 2-4 weeks, isolated colonies began to appear. Large
and healthy colonies were selected using the cloning cylinders and transferred to
individual wells in a 24-well plate. 30-50 individual clones were screened for
expression of EGFP-ENaCp.
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2.2.8.3 Making of the tetracycline inducible cell lines
The making of tetracycline inducible cell lines involved two rounds of transfection
and selection of stable clones. On the first round, M-l cells were seeded onto plastic
Petri dishes and grown to 20% confluence. The CaP04 method was used to transfect
the construct pTet-Off. After transfection, the cells were grown in the presence of a
toxic concentration of puromycin (1 pg/ml), resistance to which is encoded by the
pTet-Off vector. When individual clones had grown to colonies of 100-200 cells, they
were isolated using cloning cylinders. The next step was to perfonn transient
transfection assays with TRE-EYFP-sgkl to identify clones that showed high
transcription induction level. Cells of each clone were split into 2 single well of a 6-
well plate and transfected with 2pg TRE-EYFP-sgkl as before. Tetracycline (1 pg/ml)
was added to one of the two wells and incubated for 24 hr. +/-EYFP-sgkl expression
was screened for by fluorescence microscopy. The clones with the highest fold-
induction (highest expression with lowest background, >20 fold) were selected for
propagation (named Tet cell line). The next step was to transfect the stable Tet cell
line with the TRE-EYFP-sgkl construct. The goal was to generate a cell line that gave
low background and high expression of EYFP-sgkl. Cells were transfected with the
construct TRE-EYFP-sgkl and grown in the appropriate complete medium, 1 pg/ml
tetracycline and 300pg/ml hygromycin (resistance to which is encoded by the
pTRE2hyg vector). After 2-4 weeks, hygromycin resistant clones started to appear.
Large and healthy clones were selected and tested for the expression and induction of
EYFP-sgkl.
2.2.9 Western BlotAnalysis
M-1 cell homogenates were prepared from confluent cell monolayers and pelleted by
centrifugation (1,000 g). The pellet was solubilized in the sodium dodecyl sulfate
(SDS) lysis buffer. The homogenate was centrifuged in a microcentrifuge and its
supernatant was separated by 8% polyacrylamide gel electrophoresis. After
electrophoresis, the separated proteins were electrophoretically transferred to a
polyvinylidene difluoride (PVDF)-blotting membrane and the membrane was blocked
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with 5% milk to prevent nonspecific binding and probed with an anti-GFP antibody
(1:1,000 dilution), followed by binding of a secondary goat anti-mouse horseradish
peroxidase IgG (1:5,000 dilution). The specific binding was detected using a
peroxidase-based chemiluminescent detection method (ECL) according to the
manufacturer's instructions.
2.2.10 Fluorescence Activated Cell Scanning (FACS)
For each M-l cell population, 1,000 cells were subjected to FACS analysis to quantify
their fluorescence intensity at the EG(Y)FP emission wavelength band <560nm
(known as FL-1 or green channel) v.v that at 560-640nm (known as FL-2 or red
channel) as an index of non-specific emission. Data analysis was carried out using the
CELLQuest software.
2.2.11 Staining ofCell Organelles and Plasma Membrane
Endoplasmic reticulum was labeled for 10 rnin at room temperature with the
rhodamine-B hexyl ester (Molecular Porbes #R648) at 0.5pg/ml; mitochondrion with
MitoTracker (#M22426) at 2pM; Golgi apparatus with an anti-GM130 antibody [a
mouse anti-GM130 antibody from Dr Rory Duncan detected with an AlexFluor 660
tagged goat anti-mouse secondaiy antibody (#A21054)]; and endosomes with
AlexFluor 630-transferrin (#T23362) at lOpM. Previous studies show at high
concentrations (0.5-1 pg/ml) the rhodamine-B hexyl ester specifically stains the
endoplasmic reticulum of fixed cells (Terasaki and Reese 1992; Yang L et al. 1997).
The apical membranes were labeled on ice with rhodamine-conjugated wheat germ
agglutinin (WGA, #W849) at 2pg/ml. The Transwell filters or coverslips bearing the
stained M-l cells were then mounted onto a microscopic slide for visualization.
2.2.12 Fluorescence Microscopy.
Conventional fluorescence images were captured by a CCD camera attached to a
Zeiss 210 Axio-epifluorescence microscope using the fluorescein isothiocyanate
(FITC) filter set and a lOOx Plan-Neofluar objective (Numerical Aperture NA 1.4 oil).
Laser scanning confocal microscopy (LSCM) was performed with the Zeiss 510
confocal imaging system equipped with a Plan-Neofluar 40x (NA 1.3 oil) objective
and the rhodamine and FITC filter sets. For the dual imaging of EGFP and rhodamine,
fluorescent images were collected by exciting the fluorophores at 488 nm (EGFP) and
543 nm (rhodamine) with argon and FleNe lasers respectively. Emissions from EGFP
and rhodamine were detected with the band-pass FITC filter set of 500-550 nm and
the long-pass rhodamine filter set of 560nm, respectively. A sequential scanning
program was used to collect z-optical sections (i.e. in the transverse plane) at 0.16 pm
intervals. An overlay of collected 2D images at each depth was performed to allow a z
dimension stack yielding a 3D reconstruction then sectionable in alternative planes
(Zeiss LSM Image Browser version 3.1). Reconstructed images oriented with
coordinates (xy 0°, yz 0°, xz 90°) were used to visualize the epithelial monolayer in
sagittal section.
2.2.13 Animal Treatments
The animal work was conducted at the local animal biomedical research unit by staff
holding appropriate small animal handling personal license (including June Noble, Dr
Flelen Speirs, Dr Chris Kenyon and others) and was approved by the local ethical
committee being in accordance with the UK Home Office Animal Act 1986 under
existing project license held by Prof JR Seckl. I have only assisted these personnel in
procedures that do not require any license. Eight-week-old male C57BL/6J mice (23.5
to 25 g) were segregated into ten groups (each n=6) and caged in pairs within their
own group (Table 3.1). All mice had free access to normal diet (0.3% sodium) and
water (with saline additionally available to adrenalectomized mice). The bilateral
adrenalectomy operations were performed under gaseous anesthesia. Animals were
sacrificed by terminal anesthesia. ALZET 1007D osmotic mini-pumps (preloaded
with treatments or vehicle) were implanted subcutaneously in groups of mice having
aldosterone infusions with various doses (50pg/kg per d, 150pg/kg per d, and
750pg/kg per d) for 6 or 21 d. To investigate the acute effects of aldosterone,
injections of 150pg/kg aldosterone were given to mice 3 h before sacrifice.
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Additionally, one group of mice was kept on 0.03% low sodium diet for 6 d inducing
a degree of secondary hyperaldosteronism.
2.2.14 Plasma Aldosterone Assay
Experiments performed by others yielded mouse blood samples that were taken by
cardiac puncture rapidly after initiation of terminal anesthesia. Samples were then
centrifuged at 4°C for 10 min. Plasma was separated and stored at -20°C. Aldosterone
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was assayed using a I-RIA kit according to the manufacturer's instructions. The
polypropylene tubes coated with antibodies to aldosterone were filled with 200pl
calibrators (containing a series of known amounts of aldosterone) or 200j.il samples,
followed by adding 1ml aldosterone labeled with l25I and incubation at room
temperature for 18 hours. The tubes were then decanted thoroughly and counted to
reveal l25I irradiation in a gamma counter. A single calibration curve provides the
basis for determining aldosterone concentrations in the samples.
2.2.15 In Situ Hybridization
On the basis of the nucleotide sequence of a gene, primers were designed to amplify a
fragment encompassing a region (normally 150-500nt long) that had no significant
homology to other sequences. Flanking T3 and T7 phage polymerase consensus sites
were introduced by nested PCR as described previously (McDonald P et al 2000).
Single-stranded [35S]UTP-labeled RNA probes were generated using the required
RNA phage polymerases (T7 for antisense and T3 for sense probes). For each mouse,
sagittal cryostat sections (10 pm) were cut from intact kidney, which included cortex
and outer and inner medulla. Sections were thaw-mounted onto 3-amino
propyltriethoxysilane-coated slides and stored at -80°C. 4% paraformaldehyde was
used for fixation, followed by acetylation and prehybridization at 50°C for 2 h.
Hybridization with 4x10° c.p.m [35S]UTP-labeled RNA probe per slide was
performed at 50°C for 14 to 16 h and then followed by RNaseA treatment and washes
with a maximum stringency of O.lxSSC at 60°C. This follows well-established
methodology that reflects findings that show that these conditions create the high
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subsaturation/saturation riboprobe concentrations that provide specific radiolabeled
probe hybridization that reflects the amount of target RNA present. When
quantitatively detected (films with co-exposed microscale calibration standards,
dipped emulsion autoradiography and image analysis) this then allows relative
quantitation for gene expression between slides processed together. After washes,
slides were dehydrated and placed against (3-Max Hyperfilms. Three to five days of
exposure gave a satisfactory range of autoradiographs in the linear range of the films
as judged by coincident exposure of the film to radioactive microscale standards for
this purpose (calibrated for moderate P-emitters [l4C, 35S] in thin tissue slices;
Amersham International #RPA504, RPA511). All slides were then dipped in
photographic emulsion and exposed in a light tight box for 2 to 3 wk before being
developed. This optimal time was determined by the optimal exposure for the film
autoradiographs. In preliminary work, we emulsion-dipped slides with attached
microscales (such as above) and found a wide linear range (correlation, r=0.98),
relating grain-count density versus radioactivity. For all the dipped slides, grain-count
densities did not exceed this linear range. Selected sections were then counterstained
with the periodic acid-Schiff (PAS) method. The sample slides were first treated with
KOH solution (0.5% KOH in 70% aqueous ethanol) for 20 mins, followed by
treatment in 1% periodic acid (aqueous) for 5mins and in the Schiff solution (Sigma
#S5133) for lOmins.
2.2.16 Quantitative Image Analysis
Autoradiographic films were scanned on a high-resolution flatbed scanner. Developed
emulsion-dipped slides were analyzed on a Zeiss Axioskop Microscope with the
KS300 (v3) silver-grain counting software. Steps to minimize background tissue
hybridization included the employment of a postfixing acetylation procedure to block
the positively charged ammonium groups on tissue and a posthybridization RNase A
treatment to cleave unhybridized single-stranded RNA molecules. Thus, the tissue
background for antisense probes was considered as the nonspecific binding to tissue
RNA by probes with equal GC percentage, and so equal to the hybridization level on
sense control sections. When silver grains were counted in high magnification fields,
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the tissue background was normalized for each slide as follows. The background grain
density of tissue and glass on the sense control slide were measured separately. The
ratio between such paired background measurements was calculated for the slide. The
tissue background for an antisense slide was thus estimated by multiplying its glass
background by this ratio. Quantification was done by counting the number of silver
grains over areas under high-power magnification (*400) using automated image
analysis software (Zeiss KS 300) calibrated to accurately count silver grains over a
wide range of grain densities).
2.2.17 Statistical Analyses
The Statistica software package (v5) was used to analyze data. For experiments
involving multiple groups, the significance of differences between groups was tested
by ANOVA. When the all-effects F value was significant (P < 0.05), post hoc analysis
of differences between individual groups was made with the Neuman-Keuls test. For
graphical presentation, values were expressed as mean ± SE (standard error). For two-
variable correlation studies (involving generation of standard curves), the linear
regression analysis was performed to fit a line in a two-variable space defined by the
equation Y=a+b*X, so that the squared deviations of the observed points from this
line are minimized (least squares estimation).
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CHAPTER 3
SGK1 GENE EXPRESSION IN KIDNEY AND ITS REGULATION BY
ALDOSTERONE: SPATIO-TEMPORAL HETEROGENEITY AND
QUANTITATIVE ANALYSIS
3.1 Summary
The serine-threonine kinase sgkl was recently identified as a gene rapidly induced by
mineralocorticoids, resulting in increased sodium transport in vitro. To carefully
localize and quantify the renal sgkl expression response to aldosterone, I have
performed in situ hybridization on kidneys of mice having aldosterone excess over a
range of doses and durations. In control and adrenalectomized animals, the glomeruli
and inner medullary collecting ducts are the major sites of sgkl expression, which is
maintained independent of aldosterone. Sgkl upregulation induced by aldosterone
excess exhibits spatial-temporal heterogeneity. Both acute (3 hours) and chronic (6
days) aldosterone excess stimulates sgkl expression in the distal nephron, i.e. from
the distal convoluted tubules through to the outer medullary collecting ducts.
Treatments for 6 days with low sodium diet [0.03% (I)] and aldosterone infusions
[50pg/kg/day (II), 150ug/kg/day (III) and 750pg/kg/day (IV)] have generated
elevation of circulating aldosterone. Across these treatments (I-IV), the circulating
aldosterone level correlates with the progressive induction of sgkl expression, with
highly stimulated tubules first appearing in cortex (I) and continuing downward (II)
until there was a strong stimulation throughout outer medulla (III-IV). Interestingly,
chronic but not acute aldosterone excess causes a slight increase of sgkl expression in
glomerulus (30%-50%, p<0.01), and a dramatic down-regulation in the initial portion
of inner medulla, which could result from diminished interstitial osmolarity. Relative
quantification (vs control) of sgkl upregulation in individual tubules reveals: (1) a
1.8-fold increase of sgkl mRNA at 3 hours (150pg/kg injection); (2) a dose-
dependence of chronic upregulation reaching a ceiling of 8-fold elevation.
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3.2 Introduction
Regulation of sodium reabsorption in the kidney is crucial for maintenance of whole
body fluid homeostasis. The Na+ transport induced by aldosterone, either in vivo or in
vitro, is sensitive to the K+-sparing diuretic amiloride, which is a potent blocker of the
epithelial Na+ channel (ENaC) (Rossier BC 1997; Horisberger JD 1998). The major
site of aldosterone action is in the distal nephron from late distal convoluted tubules
(DCT) through to cortical collecting ducts (CCD) and outer medullary collecting
ducts (oMCD) (Doucet A et al. 1981; Farman N 1992). Two phases are distinguished
in regulation by aldosterone of sodium transport: an early phase starting after a lag
period of 20 to 60 minutes, during which the pre-existing channels and Na+/K+-
ATPase pumps are activated, and a late phase (>2.5 hours), which involves increasing
contribution from newly synthesized channel and pump proteins (Verrey F 2000).
In the A6 Xenopus cell line, which is a good model of mammalian distal nephron,
efforts have been made to elucidate the pathway of aldosterone action, leading to the
finding of an early-response gene, sgkl (serum/glucocorticoid kinase), the
transcription of which is rapidly (<3 hours) stimulated by aldosterone excess (Chen
SY et al. 1999). Intriguingly, sgkl was shown to significantly elevate ENaC-mediated
sodium transport via increasing the surface expression of ENaC subunits in Xenopus
oocytes (Alvarez de la Rosa D et al. 1999), which is in keeping with evidence
suggesting sgkl may facilitate a similar increased apical translocation of ENaC in
distal nephron in vivo (Loffing J et al. 2000, 2001; Masilamani S et al. 1999). Other
stimuli such as insulin, glucocorticoids and cell volume change were documented to
regulate sgkl (Perrotti N et al. 2001; Wang J et al. 2001; Webster MK et al. 1993a;
Waldegger S et al. 1997). These in vitro findings identify sgkl as a key gene in
hormonal regulation of sodium transport in cells of distal nephron. It thus becomes of
great interest to determine the distribution of sgkl in intact kidney and study its
hormonal regulation in vivo.
Previous animal studies have focused on the short-term (0.5hr-4hr) effect of
aldosterone on sgkl expression (Chen SY et al. 1999; Brennan FE and Fuller PJ 2000;
57
Bhargava A et al. 2001). Here I aim to elucidate, firstly, whether regulation of sgkl
expression is consistent with its playing a role in transduction of aldosterone-driven
sodium reabsorption in distal nephron in both short term (acute) and chronic
hyperaldosteronism. Secondly, I look for evidence of other potential regulators of and
roles for sgkl in kidney. In particular, sgkl expression may exhibit an aldosterone
dose dependence in such a way that a plateau or a peak occurs at a dose beyond which
there is no further induction or even a fall off in the degree of sgkl induction. This
would be of particular interest as it may identify a response moderating aldosterone-
sgkl driven sodium retention and imply that 'escape' from aldosterone-induced Na
retention is contributed to by such a mechanism (i.e. the reaching of the ceiling of
sgkl expression translates to the peaking of sodium reabsorption induced by sgkl and
its related pathway). Finally, these detailed studies on a wide range of aldosterone-
related treatments will allow a clearer view of sgkl expression and regulation along
the nephron and will help to guide future studies. To address these issues, I performed
in situ hybridization using radiolabeled riboprobes, autoradiographic films and silver
grain counting, which are well established as means of relative quantitation of
expression level (Wilkinson DG 1998). This approach allows comparison of sgkl
mRNA expression levels in renal regions and nephron segments.
3.3 Methods
(The materials and common molecular biology methods are described in CHAPTER 2)
3.3.1 Animal Treatments
The animal work was conducted at the local animal biomedical research unit by staff
holding appropriate small animal handling personal license (including June Noble, Dr
Helen Speirs, Dr Chris Kenyon and others) and was approved by the local ethical
committee being in accordance with the UK Home Office Animal Act 1986 under
existing project license held by Prof JR Seckl. I have only assisted these personnel in
procedures that do not require any license. Eight-week-old male C57BL/6J mice (23.5
to 25 g) were segregated into ten groups (each n=6) and caged in pairs within their
own group (Table 3.1). All mice had free access to normal diet (0.3% sodium) and
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water (with saline additionally available to adrenalectomized mice). The bilateral
adrenalectomy operations were performed under gaseous anesthesia. Animals were
sacrificed by terminal anesthesia. ALZET 1007D osmotic mini-pumps (preloaded
with treatments or vehicle) were implanted subcutaneously in groups of mice having
aldosterone infusions with various doses (50pg/kg per d, 150pg/kg per d, and
750gg/kg per d) for 6 or 21 d. To investigate the acute effects of aldosterone,
injections of 150pg/kg aldosterone were given to mice 3 h before sacrifice.
Additionally, one group of mice was kept on 0.03% low sodium diet for 6 d inducing
a degree of secondary hyperaldosteronism. Table 3.1 gives details of these groups.
3.3.2 Quantitative Image Analyses
In situ hybridization was performed upon sections (10pm) of mouse kidney using
single-stranded antisense [35S]-UTP labeled RNA probes that encompassed a region of
sgkl cDNA sequence (spanning base pairs 1091-1336, #AF205855) showing no
significant homology to other known sequences. Autoradiographic films were scanned
on a high-resolution flatbed scanner. Developed emulsion-dipped slides were
analyzed on a Zeiss Axioskop Microscope (Carl Zeiss) with the KS300 (v3) silver-
grain counting software. Steps to minimize background tissue hybridization included
the employment of a post-fixing acetylation procedure to block the positively charged
ammonium groups on the tissue surface and a post-hybridization RNase A treatment
to cleave unhybridized single-stranded RNA molecules. Thus, with use of these
methods the tissue background for antisense probes was low and considered as
nonspecific binding being no greater than the hybridization level on sense control
sections. When silver grains were counted in high magnification fields, the tissue
background was normalized for each slide as follows. The background grain density
of tissue and glass on the sense control slide were measured separately. The ratio
between such paired background measurements was calculated for the slide. The
tissue background for an antisense slide was thus estimated by multiplying its glass
background by this ratio. Quantification was done by counting the number of silver
grains over areas under high-power magnification (x400). Grain-counting involved
determining the grain density over glomeruli and tubules that highly expressed sgkl.
59
Table 3.1. Experimental groups
Group
name
Group description Infusion methods Drug-delivery rate Lasting time
Adx Adrenalectomy Vehicle" mini-pump - 6 days
Con Control Vehicle mini-pump - 6 days
Aldo50 Aldosterone Aldosterone/Vehicle
Mini-pump
50ug/kg per day 6 days
Aldol50 Aldosterone Aldosterone/Vehicle
Mini-pump
150ug/kg per day 6 days
Aldo750 Aldosterone Aldosterone/Vehicle
Mini-pump
750ug/kg per day 6 days
Aldo21d Aldosterone Aldosterone/Vehicle
Mini-pump
150ug/kg per day 21 days
Conlnj Control Saline injection - 3 hours


















Vehicle mini-pump - 6 days
a vehicle: 0.9% saline, 2% (v/v) ethanol
Identification of glomeruli was straightforward for all groups. Identification of tubules
in both cortex and outer medulla involved comparing highly expressing tubules in
animals with aldosterone excess and those in controls, where tubular expression
merged with "background" levels. Although there was some variation across non-
glomerular cortex (mean ± SE grain density, 0.0869 ± 0.0106 counts/pm2), this did
not clearly correspond to tubule outlines and was present over a wider cortical area in
control and treatment groups than the highly expressing tubules readily identifiable in
treatment groups. The best valid solution to estimate control tubular grain counts was
to measure this grain density over a larger area, (full-field [x400] view of medulla or
non-glomerular cortex) rather than individual tubules. This control expression level
was used for comparison with animals with aldosterone excess. I followed a protocol
for random selection of regions, glomeruli, and tubules, which involved aligning the
field of view over renal cortex at such low power that the viewer was unable to see
local renal structure or grain density. The view was then zoomed to x100 to x200, and
glomeruli or tubules in the central field of view were those designated to be subjected
to grain counting at x400. The process was repeated, counting ten glomeruli or
tubules (with grain-density elevated allowing them to be demarcated against
background) out of eight sampled fields in each region (for cortex and medullary
regions separately). Sampling cortical or medullary regions was carried out in the
same fashion for each kidney section. When it came to control sections, five full-field
(x400) views were counted (minus glomeruli in cortex, five rather than eight because
of their larger area). Rarely, part of the section with poor morphology was excluded
from subsequent statistical analyses. For each mouse, the mean density of each such
renal component assessed (glomeruli and cortical and medullary tubules or areas) was
then calculated.
3.4 Results
3.4.1 Renal expression profile ofsgkl
Examination of control and adrenalectomized animals revealed that sgkl mRNA had
a discrete distribution in kidney, with a punctate appearance in cortex, little expression
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in outer medulla and high abundance in inner medulla (Figure 3.1A). This expression
profile was not dependent on circulating corticosteroids, as it was maintained in
adrenalectomized animals (aldosterone <400±<100pmol/l, corticosterone <55nmol/l).
The cortical expression of sgkl was primarily confined to glomeruli (Figure 3.IB). Its
expression in glomeruli was uniform and centrally distributed (Figure 3.IE), so ruling
out the possibility that the glomerular visceral or parietal epithelium was the
expression site. This is consistent with the data from human kidney (Lang F et al.
2000), suggesting sgkl expression in the glomerular mesangium. In inner medulla, as
the papilla was approached, nearly all tubular cells strongly expressed sgkl (Figure
3.1C-D). This characteristic indicates the inner medullary collecting ducts to be the
expression location, because the number of thin limbs of Henle's loop diminishes
towards the papilla.
3.4.2 Chronic effects ofaldosterone and dosage response
A range of 6-day treatments with sodium depletion [(I) 0.03% sodium diet] and
aldosterone infusions [(II-IV) 50pg/kg/day, 150pg/kg/day and 750pg/kg/day] resulted
in sustained elevation of circulating aldosterone levels: (I) 1234±124pmol/l, (II)
4660±120pmol/l, (III) 15485+47lpmol/1 and (IV) 53569+3198pmol/l. In view of the
fact that severe sodium deficiency has been reported to increase aldosterone secretion
20-25 fold in sheep or human (Laragh JH et al. 1960; Mills JN 1962), the two higher-
dose infusions (III-IV) mimicked these physiologically extreme conditions of
aldosterone excess (25-fold and 75-fold elevation of plasma level vs 699±56pmol/l of
controls). Correlated with the elevation of circulating aldosterone across these animal
groups, there was a change in the pattern of sgkl expression, with highly stimulated
tubules first appearing in cortex (I, Figure 3.2-A and a) and continuing distally along
the nephron (II, Figure 3.2-B, b and c) until there was a strong stimulation throughout
outer medulla (III-IV, Figure 3.2-C and d). Silver-grain counting of individual tubules
showed a dose-dependent upregulation of sgkl in both cortex and outer medulla
(Figure 3.3). The mild excess of aldosterone in sodium-depleted animals (I) induced a
4.7-fold increase of sgkl expression (compared to that in kidneys of untreated control
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Figure 3.1. Sgkl expression profile in kidney. Auto radiograph (A: expression black) and
photomicrographs (B through D: dark-field, expression white; E: bright-field, expression visible silver
grains) showing sgkl expression in detail in the kidney of a normal (control) mouse. The boxes in the
autoradiograph in panel A show the sites of capture of the photomicrographs on the corresponding
kidney section slide (B: xlOO, cortex; C and D: x50, medulla). A single glomerulus was visualized in
panel E at 400 magnification. Note the abundant expression in glomeruli and inner medulla. Glom,











Figure 3.2. Chronic effects of
aldosterone on sgkl expression.
Autoradiographs (A through C:
expression black) and
photomicrographs (a through e: dark-
field, expression white) showing
sgkl expression in kidneys of animals
treated with aldosterone excess
(Magnifications: 100 in a and b; 50 in
c through e). The sites of capture of
the photomicrographs on the kidney
sections are indicated on the
corresponding autoradiographs. Note
the highly stimulated tubules
traversing from cortex to outer
medulla. T, stimulated tubules.
ceiling (8-fold) in animals infused with aldosterone (II-IV). In outer medulla, sgkl
stimulation (6.4-fold) was first observed in animals with moderate aldosterone excess
(II). The ceiling of 8-fold increase was reached at groups with more severe
aldosterone excess (III-IV). Moreover, in animals treated with 150pg/kg aldosterone
for 21 days, sgkl stimulation persisted and its pattern and extent remained similar to
that at 6 days (Figure 3.3). Finally, water intake of animals was substantially increased
by the high-dose aldosterone infusions (2-fold in the 150pg/kg/day groups and 3-fold
in the 750pg/kg/day group v.v control).
3.4.3 Acute effects ofaldosterone
In mice injected with 150pig/kg aldosterone 3 hours before sacrifice, highly stimulated
tubules were visualized in cortex and outer medulla (Figure 3.4). The rapid sgkl
induction caused by injection was completely abolished in animals pre-treated with
spironolactone (MR antagonist) (Figure 3.4), suggesting mediation via
mineralocorticoid receptors (MR). Silver-grain counting to examine the acute effects
of aldosterone revealed a 1.8-fold upregulation of sgkl in cortical tubules and 1.4-fold
in outer medullary tubules, lower than that elicited by the chronic treatments, eg 6
days and 21 days (Figure 3.5). Nevertheless I cannot rule out the possibility that a
peak of sgkl stimulation may have occurred before 3 hours, considering the short
half-life of circulating aldosterone (20 minutes) (Tait JF et al. 1961) and sgkl rnRNA
(30 minutes) (Webster MK et al. 1993b). Furthermore, other studies showed that sgkl
stimulation peaked in rat kidney within 1-2 hours following aldosterone injection
(Brennan FE and Fuller PJ 2000; Bhargava Aet al. 2001).
3.4.4 Aldosterone induction ofsgkl expression is in distal nephron
Examination of emulsion-dipped slides revealed both acute and chronic aldosterone
treatments induced sgkl expression in a minority of cortical tubules. The Periodic
Acid Schiff counterstaining method stains the brush border of proximal tubules with
pink colour. Sgkl stimulation was visualized in tubules lacking this border (Figure 3.6,
A-B and D-E), indicative of more distal tubules, which in cortex were distributed
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Figure 3.3. Quantification of sgkl expression in response to chronic aldosterone excess.
Mice were treated for 6 d with sodium depletion, low-dose (50[Jg/kg) and high-dose (150
to 750|Jg/kg) aldosterone infusions or for 21 d with 150|Jg/kg infusion. Sodium depletion
induced a 4.7-fold increase of sgkl mRNA level in cortical tubules (P<0.01 versus
control). The 50|Jg/kg infusion stimulated sgkl by 8.2-fold in cortex and 6.4-fold in outer
medulla. Sgkl stimulation by high-dose infusions for 6 or 21 d reached a ceiling of
upregulation (eightfold elevation) in cortex and outer medulla. The mean grain density in







Figure 3.4. Acute effects of aldosterone on sgkl expression. Autoradiographs (expression
black) showing comparison of sgkl expression among control (A), animals injected with




Figure 3.5. Quantification of sgkl expression in response to acute
aldosterone excess. Aldosterone-induced upregulation of sgkl mRNA
by 1.8-fold in cortex and 1.4-fold in outer medulla (P<0.01 versus
control). The mean grain density in cortical tubules of control animals
was designated as one unit.
widely across cortical labyrinths as well as in cortical medullary rays; in fact from
distal convoluted tubules (DCT) to cortical collecting ducts (CCD). Moreover, tubules
at the glomerular vascular pole exhibited sgkl induction (Figure 3.6, C and F),
suggesting involvement of the early portion of DCT. However to characterize the
DCT distribution definitively would require additional studies. Sgkl stimulation could
be seen in long single tubules extending in continuity from cortex through outer
medulla to enter inner medulla without a major change in diameter (Figure 3.2, c-e).
This pattern was fully consistent with the cortical and outer medullary collecting ducts
being sites of upregulation of sgkl expression.
3.4.5 Distinct regulation by aldosterone in glomeruli and inner medullary
collecting ducts
It was somewhat unanticipated that sgkl mRNA abundance was raised (30-50%) by
chronic (50pg/kg/day) but not acute aldosterone excess in glomeruli (Figure 3.7), a
site not regarded as a classical MR responsive target. A similar upregulation was also
detected in animals with higher doses of aldosterone infusion but not in those with
sodium depletion. Interestingly, the abundant sgkl expression in inner medulla was
downregulated in its initial portion by chronic and severe aldosterone excess (150 or
750pg/kg/day for 6 or 21 days). The degree of this effect showed some individual
variation within treatment groups and was more striking at 21 days. As illustrated in
Figure 3.2 C and e, the outer-inner medulla junction was easy to identify on the
autoradiograph, where the outer medullary collecting ducts with high sgkl expression
were adjoining the inner medulla with much repressed expression.
3.5 Discussion
The expression of sgkl mRNA and its regulation by aldosterone were studied in detail.
In kidney of control mice, I found an abundant expression of sgkl in glomeruli and
inner medullary collecting ducts, which was substantially maintained independent of
corticosteroids and thus persisted in adrenalectomized animals. Both acute and
chronic aldosterone infusions induced sgkl expression in distal tubules through to
63
Figure 3.6. Histology of renal cortical sections from aldosterone-treated groups. The images
(magnification, 100) of panels A through C were taken by phase-contrast microscopy, and D through F
are their respective counterparts under dark-field view. The cortical labyrinth (CL) is illustrated on
panel A. Panel B shows a region where a cortical medullary ray (CMR) protrudes into cortical
labyrinth. Periodic acid-Schiff (PAS) stains the brush border of proximal tubules (PT). In dark-field
view (D through F), the counterstaining caused the image to have a dark green (negative) or dark purple
(positive) background, on top of which silver grains are visible. In cortex (both CL and CMR), the
tubules in which upregulation of sgkl by aldosterone is seen are PAS-stained negative, indicating they
are tubules of the distal nephron. Glomerulus and surrounding structures are illustrated in panels C and
F. The distal tubule approximating to the vascular pole of glomerulus exhibited sgkl induction,
suggesting the possible involvement of the early portion of distal convoluted tubules. Glom,
glomerulus; VP, vascular pole; UP, urine pole; +, high expression.
Control Aldo Adx
6 days 6 days 6 days
Control Aldo
3 hours 3 hours
Figure 3.7. Quantification of sgkl expression in glomerulus. Silver grain counting
revealed a slight increase (30 to 50%) of sgkl expression induced by chronic (6 d)
but not acute (3 h) aldosterone excess (* P < 0.01 versus control).
outer medullary collecting ducts. These regions have the potential to mediate
amiloride-sensitive sodium transport, as they include the major sites of ENaC action.
Although sgkl was shown to increase the surface expression of ENaC subunits in
Xenopus oocytes (Alvarez de la Rosa D et al. 1999), a recent report suggested that
ENaC translocation to the apical membrane was limited to the proximal portion of the
distal nephron, i.e. from distal convoluted tubules to connecting tubules, in response
to rapid aldosterone infusion (2-4 hours) in rats (Loffing J et al. 2001). Both our
findings (mRNA) and reports of other groups (protein) showed that acute induction of
sgkl expression was localized to the entire aldosterone sensitive distal nephron
(ASDN: i.e. from distal convoluted tubules to outer medullary collecting ducts). An
axially heterogeneous mechanism can be proposed to control the activation of sgkl
(eg by phosphorylation), and thereby restrict ENaC translocation to the more proximal
portion of the distal nephron. Beyond previous findings, our work shows an axial
heterogeneity of prolonged upregulation of sgkl mRNA, which correlates with the
plasma level of aldosterone. It appeared that mild aldosterone excess (0.03% sodium
diet) induced sgkl in the cortical portion of ASDN whereas moderate (50pg/kg
infusion) and more severe (150pg/kg and 750pg/kg infusions) excess affected the
entire ASDN. Two recent studies, in mouse (Loffing J et al. 2000) and rat
(Masilamani S et al. 1999), have reported that treatments with chronic aldosterone
excess (Masilamani S et al. 1999) or dietary sodium restriction (Loffing J et al. 2000)
are associated with ENaC translocation to the apical membrane of distal nephron.
Dietary sodium restriction in mice caused ENaC to shift from cytoplasm to the apical
membrane in cells confined to the cortical segments of ASDN (Loffing J et al. 2000).
This could be interpreted as potentially due to the aldosterone-induced accumulation
of sgkl, which promotes ENaC trafficking into the apical membrane.
The studies described in this chapter are the first to assess sgkl regulation using in
situ hybridization in mouse as well as the first to carefully quantify the relative degree
of its induction in different parts of the nephron (distal tubules, glomeruli and inner
medulla) using silver-grain counting. Previous work has examined aldosterone
regulation of sgkl mRNA levels in renal cell lines (Chen SY et al. 1999; Naray-Fejes-
Toth A et al. 1999), the whole kidney (Brennan FE and Fuller PJ 2000; Bhargava A et
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al. 2001) or dissected renal components (Loffing J et al. 2001; Shigaev A et al. 2000)
by northern blotting or RT-PCR, as well as demonstrated the accumulation of sgkl
protein in response to hormone excess by immunohistochemistry (Chen SY et al.
1999; Loffing J et al. 2001). As the current work examines the effects of a wider range
of treatments (Table 3.1) this allows a clearer view of the way aldosterone affects
sgkl expression across the nephron. In the present study, up to 8-fold increase of sgkl
mRNA was found in individual renal tubules in response to chronic aldosterone
excess and 1.8-fold to acute excess. The upregulation of sgkl mRNA exhibited dose
dependence over a range of circulating aldosterone (2 to 75-fold elevation). The fact
that the induction of sgkl exhibited a ceiling (8-fold elevation) in animals with severe
aldosterone excess suggests that the aldosterone-sgkl-ENaC pathway responses reach
saturation at this level. It is possible that this relates to saturation of available MR
sites.
The mediator that upregulated sgkl in glomeruli remains unclear. It is possible that at
high doses, aldosterone will to some degree bind to GR (glucocorticoid receptors) and
subsequently induce sgkl expression (Yan K et al. 1999; Escoubet B et al. 1996).
However circulating physiological glucocorticoid levels (MacDonald P et al. 2000)
supply a better GR ligand at even higher levels than the raised plasma aldosterone in
our aldosterone excess groups, especially the 50pg/kg/d group which nonetheless
exhibits this glomerular sgkl upregulation. Moreover adrenalectomy does not abolish
glomerular sgkl expression indicating other non-corticosteroid pathways are involved.
As elevated mesangial sgkl in diabetic nephrons has been thought to follow altered
GFR (Lang F et al. 2000) it may be that glomerular haemodynamic changes during
chronic aldosterone excess initiate the mesangial sgkl upregulation.
The axial osmolality gradient in the renal medulla is made up of gradients of several
individual solutes, including NaCl and urea. In antidiuresis, progressive increases in
tissue NaCl and urea concentration and osmolality are observed along the
corticomedullary axis from the cortex to the papilla. In contrast, the gradients are
markedly attenuated during water diuresis (Hai MA et al. 1969). I propose an osmotic
theory to explain the high abundance of sgkl expression in inner medullary collecting
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ducts, although I cannot rule out the possibility of sgkl expression additionally in
interstitial cells. Evidence from other research supports this proposal and it seems that
the extracellular hypertonicity or cell shrinkage can stimulate sgkl expression in vitro
(Waldegger S et al. 1997). Thus, a certain osmotic threshold sufficient to induce sgkl
may be reached at the outer-inner medullary junction. The unexpected down-
regulation of sgkl in inner medulla induced by severe aldosterone excess indicates the
engagement of regulatory mechanisms other than MR mediation. Possibly the osmotic
gradient was partially washed out by the increased water intake (2-fold in the
150pg/kg/day groups and 3-fold in the 750pg/kg/day group v.v control), which was
elicited by longer-term and more severe aldosterone excess. Hence, in such a partial
"wash-out", the osmotic gradient including the threshold at which sgkl was
stimulated would move further distally towards papilla so this may explain the
reduction of sgkl expression in the initial part of inner medulla. Although further
investigation is required, as there is an individual variation in fluid intake within
chronic and severe aldosterone excess groups, it may account for the corresponding
variation in the degree to which inner medullary sgkl expression is downregulated
under these circumstances. The action of sgkl in inner medulla is unclear but it could
be involved in controlling cell volume in face of high interstitial osmolal ity towards
the papilla. Additionally it could be involved in regulating sodium reabsorption in
inner medullary collecting ducts. In the latter case, a reduction in sgkl expression
with prolonged aldosterone infusion might contribute to facilitating natriuresis in
'escape' from the sodium retention induced by aldosterone.
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CHAPTER 4
IDENTIFICATION AND CHARACTERIZATION OF ALDOSTERONE
INDUCED GENES
4.1 Summary
The signaling pathway of aldosterone plays a key role in maintenance of the
extracellular fluid homeostasis. Largely unknown to date are the genes whose
expression is regulated by aldosterone. In this study, I have screened through 21
candidate genes (including 29 isoforms in total) by in situ hybridization and reported
the identification of U12b, a glutathione S-transferase isoform, as being
downregulated by aldosterone.
4.2 Introduction
Aldosterone influences expression of a broad pool of genes, the protein products of
which transduce the actions of aldosterone in the nucleus out to the plasma membrane,
where its final effectors (ENaC and Na+/K+-ATPase) are located (Verrey F 2000;
Pearce D 2001). The next aim ofmy PhD studies was to identify and characterize the
genes that are transcriptionally regulated by aldosterone in the distal nephron. The
strategy to achieve these aims involved: 1, systematically screening a large pool of
candidate genes including those playing a pivotal role in the aldosterone pathway
(MR and 11 (3-HSD2); those discovered by others and shown to be regulated by
aldosterone (such as sgkl and K-Ras) and those generated in the host laboratory. In
our group (Brown RW unpublished data), a source of candidate genes was generated
by comparing whole-kidney mRNA (transcriptome) from mice treated with and
without clironic aldosterone infusion (50pg/kg/day for 6 days). By this strategy, genes
directly regulated by the aldosterone-MR pathway (AIPs) in the distal nephron should




As reported in Chapter 3, in situ hybridization clearly showed sgk upregulation by
aldosterone. Such regulation was further quantified by the silver-grain counting,
which assured the authenticity of differences between groups. By using the same
groups as in the previous sgk studies, candidate genes were screened. Initially, one or
two mice chosen from each of the groups treated with adrenalectomy (Adx), control
(Con) and aldosterone (Aldo) infusion (50pg/kg for 6 days) were compared. If the
results were encouraging, a full-scale comparison with n=6 in these groups was
undertaken by in situ hybridization.
4.4 Results
I have screened through 21 genes in total (including 29 isoforms), involving one
mouse from each of the groups Adx, Con and Aldo. The data are summarized in Table
4.1-2. Autoradiography images of the renal profile of the genes screened are shown in
Figure 4.1-2. Among these genes, four (MR, 11P-HSD2, Ki-RasA, and ul2b) were
selected for further study on the basis of prior knowledge or possible changes in the
initial work. This involved groups of 6 mice from each treatment (Adx, Con and
Aldo).
MR and 11 (3-HSD2 mRNAs showed similar expression profiles, with hybridization
signals detected over long single tubular structures extending in continuity from the
cortex through the outer medulla and ending at the outer-inner medullary junction.
This pattern is fully consistent with localization to the cortical and outer medullary
collecting ducts. Ki-RasA mRNA had a more uniform distribution throughout the
cortex and outer medulla. Interestingly, Ki-RasA was not expressed in inner medulla.
Nevertheless, the hormonal regulation studies did not show any significant regulation
ofMR, 11P-HSD2, and Ki-RasA mRNAs in any renal subregion (Figure 4.3).
Image analysis showed ul2b mRNA expression was significantly regulated by
aldosterone. U12b is an isoform of the mu class of glutathione S-transferase (GST-
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U1 Yes No significant difference
U2A Yes No significant difference
U2B Yes No significant difference
U3 No No significant difference
U4 Yes No significant difference
U5A Yes No significant difference
U5B Yes No significant difference
U6 No No significant difference
U7A No No significant difference
U7B No No significant difference
U8 Yes No significant difference
U9 Yes No significant difference
U10 Yes No significant difference
Ull No No significant difference
U12 Yes No significant difference
U12A Yes No significant difference
U12B Yes Downregulation in inner medulla
U12F Yes No significant difference
U13 No No significant difference
UI4 Yes No significant difference
U15 Yes No significant difference
U16 No No significant difference
D1 No No significant difference
D2 No No significant difference
D4A No No significant difference
D4B No No significant difference
MR Yes No significant difference
11P-HSD2 Yes No significant difference
Ki-RasA Yes No significant difference
Table 4.2 Renal distribution
Name Cortex Outer Medulla Inner Medulla Comments on expression pattern
U1 low low low Regional difference not apparently identified
U2A low high (OS)/ low (IS) low Clear difference among cortex, OS/IS of outer
medulla and inner medulla
U2B low high (OS)/ low (IS) low Clear difference among cortex, OS/IS of outer
medulla and inner medulla
U3 high not expressed not expressed Expressed only in cortex
U4 high low (OS)/high (IS) not expressed Clear difference among cortex, OS/IS of outer





low High expression in IS of outer medulla
U5B low not expressed (OS)/
high (IS)
high Clear difference among cortex, OS/IS of outer
medulla and inner medulla
U6 high low not expressed Clear difference among cortex, outer medulla
and inner medulla
U7A low low (OS)/high (IS) low Clear difference among cortex, OS/IS of outer
medulla and inner medulla
U7B low low (OS)/high (IS) low Clear difference among cortex, OS/IS of outer
medulla and inner medulla
U8 low low low Regional difference not apparently identified
U9 low low low Regional difference not apparently identified
U10 low high high Clear difference between cortex and medulla
Ull low low not expressed Clear difference between cortex and medulla
U12 low high (OS)/ low (IS) low Clear difference among cortex, OS/IS of outer
medulla and inner medulla
U12A low high (OS)/ low (IS) low Clear difference among cortex, OS/IS of outer
medulla and inner medulla
U12B low low high Clear difference between cortex and medulla
UI2F low low low Regional difference not apparently identified
U13 low high (OS)/ low (IS) low Clear difference among cortex, OS/IS of outer
medulla and inner medulla
U14 low high (OS)/ low (IS) not expressed Clear difference among cortex, OS/IS of outer
medulla and inner medulla
U15 low high (OS)/ low (IS) low Clear difference among cortex, OS/IS of outer
medulla and inner medulla
U16 low low low Regional difference not apparently identified
D1 low low low Regional difference not apparently identified
D2 low low low Regional difference not apparently identified
D4A low low low Regional difference not apparently identified
D4B low low low Regional difference not apparently identified
MR high high not expressed Clear difference between cortex and medulla
11(5-
HSD2
high high not expressed Clear difference between cortex and medulla
Ki-
RasA
high high not expressed Clear difference between cortex and medulla
X OS: Outer stripe of outer medulla; IS: Inner stripe of outer medulla.
Figure 4.1. Autoradiography images of the renal profile of the genes screened through.
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Figure 4.3. Regional densitometric analysis of mRNA expression of MR (A),
11P-HSD2 (B) and Ki-RasA (C). No significant regulation of MR, 11|3-HSD2
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Figure 4.4. Aldosterone effects on ul2b expression. Autoradiographs (expression
black) showing comparison of ul2b expression between control (A) and animals
infused with 50pg/kg aldosterone for 6 d (B). Note the downregulation of ul2b in
inner medulla (arrow).
mu2) (Brown RW unpublished data). GST-mu2 was expressed from cortex to medulla,
with prominent expression in inner medullary collecting ducts converging towards the
papilla. Chronic aldosterone excess reduced the expression of GST-mu2 mRNA in
inner medulla (Figure 4.4), but not in other subregions of the kidney. This gene was
further investigated by Speirs HJL and Hou J et al (2001), with the work encompassed
by this thesis.
4.5 Discussion
As reported in Chapter 3, in situ hybridization clearly showed sgk to be upregulated
by aldosterone. Furthermore, the localization of gene expression and regulation was
easily spotted with the aid of microscopic analysis. The expression level was
quantified using silver-grain counting, which assured the authenticity of differences
between groups. By this approach, I have screened through other candidate genes
including MR, 11 (3-HSD2, Ki-RasA and those discovered previously in the host lab.
MR and 11 (3-HSD2 are two key genes involved in the signaling pathway of
aldosterone. A tantalizing hypothesis is that aldosterone may modulate the expression
level of MR and/or llp-HSD2 to form an auto-feedback mechanism to amplify or
reduce its effects in mineralocorticoid-sensitive cells. It has long been known that GR,
a close homologue of MR, is regulated by glucocorticoids themselves in various
tissues (Kalinyak JE et al 1987; Rosewicz S et al 1988). However, my in situ
hybridization studies have largely ruled out significant autoregulation of MR and/or
11P-HSD2 mRNAs by aldosterone in any kidney subregion. This is consistent with
other reports that in vivo changes in aldosterone status showed no effects on 11P-
HSD2 activity, 11P-HSD2 transcripts or MR transcripts in the kidney (Alfaidy N et al
1995; Farman N and Bocchi B 2000). The advantage of in situ hybridization approach
is that it allows anatomical regions to be identified and subtle region-specific effects
to be defined. None was found for MR or 11P-HSD2 mRNAs. A disadvantage is the
semi-quantitative nature of the technique, but here all sections from all 3 treatment
groups were hybridized to the same probe in a single experiment. Thus comparisons
between groups should be valid giving some confidence in the intergroup and
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interregional comparisons made. Finally, this study examined mRNA not protein, but
the major mode of action of corticosteroids is upon gene expression at a
transcriptional level, underlining my basic motivation to employ this approach.
Ki-RasA was identified as an aldosterone-induced transcript in Xenopus renal A6 cells
(Spindler B et al 1997; Stockand JD et al 1999). In a mammalian collecting duct cell
line, however, Ki-RasA gene expression was found to be unchanged by aldosterone
(Robert-Nicoud M et al 2001). My studies also showed no significant change in the
mRNA level of Ki-RasA in response to aldosterone in vivo in mouse, and thus
supported the view that, unlike Sgkl, the candidacy of Ki-RasA as an important
intermediary gene in the aldosterone pathway in mammalian kidney remains in doubt.
My study was the first to identify ul2b, a glutathione S-transferase (GST) isoform
mu-2, as being downregulated by aldosterone in the kidney. GSTs are soluble
cytosolic proteins that can be grouped into eight classes: alpha, kappa, mu, omega, pi,
sigma, theta and zeta, based on amino acid sequence homologies and subunit
assembly (Sheehan D et al 2001). GSTs play an important role in the cellular
detoxification of electrophilic xenobiotics and can also act as antioxidants (Wilce
MCJ, Parker MW 1994). It is intriguing to notice that the downregulation of GST-
mu2 by aldosterone occurs only in inner medullary collecting ducts, where MR
expression is absent (Figure 4.2-3). This suggests that regulation of GST-mu2 by
aldosterone is due to a secondary effect of aldosterone. The mechanism underpinning
GST-mu2 downregulation in inner medulla is probably the same as proposed in
Chapter 3.5 to explain the downregulation of sgkl in inner medulla in response to
severe and chronic aldosterone excess. The axial osmolality gradient in renal medulla,
washed out by increased water intake (due to aldosterone excess), may have caused
the downregulation of GST-mu2 as well as sgkl. Previous studies have shown that
stress (including extracellular hypertonicity or cell shrinkage) can stimulate sgkl
expression in vitro (Waldegger S et al. 1997). Further studies to investigate whether
GST-mu2 expression responds to stress (such as cell volume change) are potentially
interesting. Recently, it has been found that GSTs modulate the signaling pathway of
JNK and apoptosis signal-regulating kinase, both of which are stress activated
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signaling pathways (Adler V et al 1999; Cho SG et al 2001).
Although some of the other candidates had a substantial expression in kidney, no
significant difference was observed comparing the group given aldosterone treatment
with controls in the initial phase of screening. Future studies may include a larger
number of individuals (n>6) and in situ hybridization to examine for even more subtle
changes in expression; or may require a more sensitive approach, such as real-time
PCR analysis of microdissected nephron segments. The latter might be crucial to
identification of aldosterone-induced genes in the microdissected distal nephron, as
the distal nephron cells constitute less than 20% of the cell population of the kidney.
An alternative may be to examine the regulation of some of the candidate genes in
cultured distal nephron cells, for example the mouse M-l cells.
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CHAPTER 5
TRAFFICKING OF THE EPITHELIAL SODIUM CHANNEL (ENAC) IN
MOUSE COLLECTING DUCT CELLS AND INFLUENCES OF EPITHELIAL
POLARITYAND HORMONES
5.1 Summary
Regulation of the epithelial sodium channel (ENaC) trafficking in cells of the distal
nephron is of major importance in control of sodium reabsorption and blood pressure.
The molecular events underpinning ENaC trafficking to and from the plasma
membrane and their hormonal regulation are poorly understood. To start elucidating
these pathways I have generated stable mouse collecting duct cell (M-l) lines that
express an N-terminally fused EGFP-ENaC|3 subunit. The cell lines grow normally,
express easily visualized quantities of the EGFP fused ENaC subunit and form
confluent epithelia with high transepithelial resistance when grown on semi¬
permeable filters. Imaging by confocal microscopy revealed that ENaC was confined
to the endoplasmic reticulum (ER) in unpolarized M-l cells. Activation of the
vasopressin pathway (forskolin) results in ENaC exodus out of the ER and entering
intracellular vesicles and this stimulated ENaC trafficking does not involve the
endocytic vesicle pathway. When cells are fully polarized, ENaC largely exits the ER
and the Golgi apparatus. Corticosteroids (>100nM dexamethasone) profoundly alter
the trafficking of ENaC proteins in polarized M-l cells by promoting ENaC
translocation to the apical membrane. Collectively, polarization, corticosteroids and
forskolin modulate the trafficking of ENaC in distinctive manners such that forskolin
or polarization fosters ENaC trafficking from ER to intracellular vesicles, whereas
corticosteroids play a role further downstream in the cascade of ENaC trafficking
events by increasing delivery of ENaC to the apical membrane.
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5.2 Introduction
Regulation of sodium reabsorption in kidney is crucial for maintenance ofwhole body
fluid homeostasis (Guyton and Hall 2000). The epithelial sodium channel (ENaC) in
the apical membrane of aldosterone responsive cells of the distal nephron mediates
entry of Na+ into these cells, which exits in exchange for K+ at the basolateral side via
the Na+/K+-ATPase (Rossier BC 1997; Horisberger JD 1998). ENaC comprises three
homologous subunits (a, p and y), arranged in a stoichiometry of 2a:ip:ly (Firsov et
al. 1996, 1998). Each subunit is composed of two transmembrane domains, an
extracellular loop and short N- and C-termini (Canessa et al. 1993, 1994). Maximal
surface expression of the channel complex is reached when all three ENaC subunits
are expressed in X. laevis oocytes, even though expression of a alone and aP or ay
two-subunit combinations can lead to appearance of a minute (<1%, 5% and 5%
respectively) quantity of 'partially functional' channel proteins on the plasma
membrane (Canessa et al. 1994; Firsov et al. 1996; Konstas A and Korbmacher C.
2003).
It is widely accepted that ENaC processing and maturation are inefficient, such that
around 1% of channels synthesized in the endoplasmic reticulum (ER) actually
translocate to the cell surface when they are expressed in X. laevis oocytes (Valentijin
JA et al. 1998) and an estimated 20% in A. laevis A6 cells (Weisz OA et al. 2000). An
important determinant of the efficiency of ENaC maturation is the assembly of its
subunits in the ER. ENaC assembly likely occurs very early during its processing in
the ER, as suggested by studies on ENaC glycosylation (Adams CM et al. 1997).
Epithelial cells display an additional layer of complexity in that they are polarized and
possess two distinct plasma membrane domains, apical and basolateral. This plasma
membrane polarity is established and maintained by protein sorting and specific
vesicle trafficking in exo- and endocytic pathways. Largely unknown to date are the
molecular pathways mediating the trafficking of ENaC to the apical surface of
polarized renal epithelia, although evidence implicating the SNARE (soluble N-
ethylmaleimide-sensitive factor attachment protein receptor) (Qi J et al. 1999; Saxena
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S et al. 1999) and the lipid 'raft' pathways has been reported (Prince LS et al 1998,
1999).
Corticosteroids are the primary hormones responsible for maintaining sodium
reabsorption in the distal nephron of kidney. The early phase of corticosteroid action
is often demarcated as the period when the pre-existing ENaC channels in the plasma
membrane are activated; and the late phase (>3h) is when de novo synthesis of ENaC
and its translocation to the plasma membrane take place (Verrey F et al 2000).
Arginine-vasopressin (AVP) evokes an increase in ENaC conductance in models of
the distal nephron that develops over a period of 5-20 min and that is synergistic to
the effect of corticosteroids (Breyer MD and Ando Y 1994). The effect of AVP is
mediated via AVP binding to its V2 receptors, leading to the stimulation of adenylate
cyclase and a concomitant increase in the level of intracellular cAMP. Nevertheless
controversy surrounds the precise mechanism underpinning the AVP effect, though
some concur that AVP promotes an exocytic delivery of ENaC to the apical membrane
(Kleyman et al 1994; Marunaka and Eaton 1991; Snyder PM. 2000).
Previously studies on characterizing ENaC processing and trafficking were conducted
primarily in non-epithelia [e.g. X. laevis oocytes] (Valentijin JA et al. 1998; Shimkets
RA et al 1997) or epithelia with less resemblance to the mammalian distal nephron
[e.g., COS cells, HEK-293 cells (Prince LS et al 1998, 1999), Madin-Darby canine
kidney (MDCK) epithelial cells (Hanwell D et al. 2002) or A. laevis A6 cells (Weisz
OA et al. 2000)]. As these are not cells of mammalian distal nephron origin they have
shortcomings in modeling the high resistance mammalian epithelia normally
expressing ENaC. In this study, I have generated mouse collecting duct cell lines (M-l)
that stably express the ENaCp subunit fused to the enhanced green fluorescent protein
(EGFP). Using this I have firstly detennined the subcellular localization of EGFP-
ENaC in M-l cells by confocal microscopy. Secondly, I have examined the trafficking
of channel proteins in response to stimulation of the hormonal pathways (including
corticosteroids and AVP). Finally, 1 have studied changes in ENaC subcellular
localization and its response to hormonal stimulation in M-l cells and how this alters
depending upon the state of cell polarity.
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5.3 Methods
(The materials and common molecular biology methods are described in CHAPTER 2)
5.3.1 Staining ofcell organelles andplasma membrane
Endoplasmic reticulum was labeled for 10 min at room temperature with the
rhodamine-B hexyl ester (#R648, Molecular Probes) at 0.5pg/ml; mitochondrion with
MitoTracker (#M22426) at 2pM; Golgi apparatus with an anti-GM130 antibody [a
mouse anti-GM130 antibody (gift of Dr Rory Duncan) detected with an AlexFluor
660 tagged goat anti-mouse secondary antibody (#A21054)]; and endosomes with
AlexFluor 630-transferrin at lOpM (#T23362). Previous studies show at high
concentrations (0.5-1 pg/ml) the rhodamine-B hexyl ester specifically stains the
endoplasmic reticulum of fixed cells (Terasaki and Reese 1992; Yang L et al. 1997).
The apical membranes were labeled on ice with rhodamine-conjugated wheat germ
agglutinin (#W849) at 2pg/ml. The Transwell filters or coverslips bearing the stained
M-l cells were then mounted onto a glass slide for microscopic visualization.
5.3.2 Fluorescence microscopy.
Conventional fluorescence images were captured by a CCD camera attached to a
Zeiss 210 Axio-epifluorescence microscope using the fluorescein isothiocyanate
(FITC) filter set and a lOOx Plan-Neofluar objective (Numerical Aperture NA 1.4 oil).
Laser scanning confocal microscopy (LSCM) was performed with the Zeiss 510
confocal imaging system equipped with a Plan-Neofluar 40x (NA 1.3 oil) objective
and the rhodamine and FITC filter sets. For the dual imaging of EGFP and rhodamine,
fluorescent images were collected by exciting the fluorophores at 488 nm (EGFP) and
543 nm (rhodamine) with argon and HeNe lasers respectively. Emissions from EGFP
and rhodamine were detected with the band-pass FITC filter set of 500-550 nm and
the long-pass rhodamine filter set of 560nm, respectively. A sequential scanning
program was used to collect z-optical sections (i.e. in the transverse plane) at 0.16 pm
intervals. An overlay of collected 2D images at each depth was performed to allow a z
dimension stack yielding a 3D reconstruction then sectionable in alternative planes
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(Zeiss LSM Image Brower version 3.1). Reconstructed images oriented with
coordinates (xy 0°, yz 0°, xz 90°) were used to visualize the epithelial monolayer in the
sagittal plane.
5.4 Results
5.4.1 Characterization of the transgenic cell lines
The full-length mouse ENaCp subunit cDNA was cloned and ligated to the carboxy
terminus of EGFP cDNA to generate a chimeric protein (Figure 5.1 A). Expression of
the EGFP-ENaCp construct was driven by the cytomegalovirus promoter. Previous
studies show that the PY motif at the carboxy terminus of the ENaCp subunit is
involved in the endocytosis of the channel proteins. To avoid potential disruption of
ENaC trafficking, 1 therefore fused the EGFP to the amino terminus of the ENaCp
gene. In addition, Chalfant ML et al (1999) reported that fusion of EGFP to the amino
terminus of the ENaCp protein had no effect upon the ENaC-mediated sodium
transport when the chimeric ENaCP protein was compared to unmodified ENaCp in
co-expression studies with the other two subunits inA laevis oocytes. Thereafter, M-l
cells were transfected with the EGFP-ENaCp construct and among the 30 lines
selected, I analyzed two lines expressing easily-visualized quantities of EGFP-ENaCp
proteins. Comparable to the parent M-l cells, both cell lines exhibited high
transepithelial resistance (>1,000 FTcm2) when fully polarized. To verify that the
EGFP-ENaCp was expressed in the clonal cell lines, 1 analyzed the EGFP fusion
protein product by western blotting. A distinct band with a molecular weight of
~110kDa (GFP: 40kDa and ENaCp 70kDa) was detected on the PVDF membrane
probed with an anli-GFP antibody (Figure 5.IB). The parental M-l cells did not
contain a similar epitope. By FACS analysis, I found both cell lines were highly pure
in that 87% of cells of the cell line EGFP-ENaCl expressed the GFP fusion protein;
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Figure 5.1. Characterization of stable M-l cell lines expressing EGFP-ENaC P proteins. A:
schematic of the expression vector plasmid. CMV, cytomegalovirus promoter; EGFP: enhanced
green fluorescence protein; ENaC P: epithelial sodium channel beta subunit. B: Western blotting
analysis of the EGFP-ENaCp stable cell lines. The position of the molecular weight standards (in
kDa) is shown at left. A distinct band with the molecular weight of ~1 lOkDa was found in the
stable cell lines (EGFP-ENaC 1 and 2) but not in the control (parental M-l cells). C: FACS
analysis of EGFP-ENaCp stable cell lines. The fluorescence intensity graphs show dots
representing cells from each cell line with their FL-1 (green channel) values v.v FL-2 (red channel)
values. Those that do not express GFP fusion proteins (control) are found along the diagonal of
this graph (i.e. where values in FL-1 equals those in FL-2). Those that express EGFP fusion
proteins have FL1>FL2 and are shifted below the diagonal towards the horizontal axis (in red).
5.4.2 ENaC is confined to the endoplasmic reticulum in unpolarized M-l
cells
To determine the localization of the ENaC fusion protein in unpolarized cells, I
sparsely seeded cells onto glass coverslips and incubated them overnight (i.e., 16-18
h). Examination of the fluorescence micrograph (Figure 5.2) of the M-l cells revealed
that the channel proteins had a cytoplasmic distribution, with a fine reticular network
all over the cytoplasm and around the nuclear envelope. This subcellular distribution
of channel proteins was fully consistent with their localization being in the
endoplasmic reticulum (ER). Some cells displayed one or more large vacuolar
compartments that excluded the accumulation of EGFP-ENaCp (Figure 5.2). Early
studies have shown similar structures in MDCK cells having prolonged inhibition of
epithelial polarity and that this compartment bore some structural resemblance to the
plasma membrane (Vega-Salas et al. 1987). To confirm the chimeric ENaC protein is
localized to ER, I examined the green fluorescence pattern of EGFP-ENaC counter-
staining with various established organelle and membrane markers. The ER
membrane was specifically stained with the red fluorescent dye rhodamine-B hexyl
ester, the mitochondrion membrane with the far-red dye MitoTracker and the plasma
membrane with the wheat germ agglutinin (WGA) conjugated to a red fluorophore.
Merging the fluorescence channel of rhodamine-B hexyl ester (Figure 5.3 Al, red)
with EGFP-ENaC (Figure 5.3 A2, green) demonstrated the co-localization of the
ENaC proteins with ER, as shown in yellow on Figure 5.3 A3. Corresponding studies
ruled out the possibility that ENaC resided in the mitochondrion (Figure 5.3 Bl-3).
WGA labeled the plasma membrane and delineated its boundary (Figure 5.3 CI). As
illustrated in Figure 5.3 C2-3, the EGFP-ENaCp fusion proteins were localized to the
ER rather than the cell membrane. To determine the corticosteroid effects on ENaC
trafficking in M-l cells, I gave cells 24-h treatments with a range of doses of
dexamethasone (Dex: lOnM, lOOnM and lpM). As a control group, cells were
cultured in the presence of lOOnM Dex plus an excess amount of glucocorticoid
antagonist (RU486 1 OuM). Each treatment group comprised three independent
experiments. I found the restricted ER localization of ENaC persisted in all of the Dex
treatment groups as well as the control group.
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Figure 5.2. Fluorescence images of the M-l cells stably expressing EGFP-ENaC|3 subunit. Cells
were grown on coverslips, fixed and mounted as described under Methods . Fluorescence images
were captured by the Zeiss Axio-epifluorescence microscope (xlOO, NA1.4). Note the EGFP
chimeric proteins are located in the nuclear envelope and cytoplasmic structures with the
appearance of a fine reticular network (white unfilled arrow) whilst the large vacuolar
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Figure 5.3. Comparison of the EGFP-ENaC(3 subcellular localization to the ER, the
mitochondrion and the plasma membrane. The M-l cells were grown on coverslips and the
fluorescence images ofM-l cells were captured by confocal microscopy (x40, NA1.3). The cell
shown in panel A1 was stained with the ER marker and A2 showed the localization of EGFP-
ENaC in this cell. Note the extensive co-localization between ENaC and ER in A3 (yellow or
orange) after A1 was merged with A2. The labeling of mitochrondrion and plasma membrane is
shown in B1 and CI respectively. B2 and C2 reveal the ENaC subcellular localization. The
merged images in B3 and C3 show adjacent red and green indicating a lack of co-localization.
5.4.3 Activation of the AVP pathway results in ENaC exodus out of the ER
and this stimulated ENaC trafficking does not involve the endocytic vesicle pathway.
To activate the AVP pathway, I exposed the unpolarized M-l cells to a downstream
activator of this pathway (50pM forskolin: a direct activator of adenylate cyclase) for
30 min. The chimeric EGFP-ENaC proteins accumulated in small punctate structures
suggestive of intracellular vesicles (Figure 5.4A). Counter-staining the ER showed a
clear segregation of ENaC localization separate from the ER (Figure 5.4 Bl-3). To
test whether ENaC trafficking occurs via endosomes upon exiting the ER, I labeled
both internalized and recycling endosomes with a transferrin red fluorophore
conjugate (Ghosh RN et al. 1994). As shown in Figure 5.4 Cl-3, I found that ENaC
largely resided in a structure distinct from the endosomes, though there was some
incidental overlap towards the cell periphery. Thus the population of vesicles to which
ENaC traffics from ER upon foskolin treatment is not within the endosomal pathway
and hence rather appears within an exocytic pathway with potential to deliver the
cargo protein (ENaC) to the plasma membrane.
5.4.4 ENaC exits the ER and the Golgi apparatus when cells are fully
polarized
To determine the localization of the ENaC fusion protein in polarized cells, I cultured
cells on Transwell polycarbonate filters for at least 10 days until high transepithelial
resistance (>1,000 fFcm2) was reached. After the M-l cells were polarized,
endoplasmic reticulum (ER) and Golgi apparatus were labeled with rhodamine-B
hexyl ester and an antibody against the Golgi membranes respectively. Merging the
channel of ER fluorescence (Figure 5.5 Al) with that of the EGFP fusion protein
(Figure 5.5 A2) indicated that ENaC was not co-localized to this organelle (Figure 5.5
A3). The staining of the Golgi apparatus manifested as tubular structures close to the
periphery of the nucleus (Figure 5.5 Bl). Image analysis revealed some co-
localization between ENaC and the Golgi apparatus (Figure 5.5 B3). Nevertheless, the
majority of ENaC proteins appeared to be excluded from the ER and the Golgi
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Figure 5.4. Forskolin effect on ENaC trafficking. Unpolarized M-l cells were exposed to 50uM
forskolin (a downstream activator of the vasopressin pathway). The fluorescence image ofM-l
cells (A) was captured by the Zeiss Axio-epifluorescence microscope (xlOO, NA 1.4); and images
(B-C) by the Zeiss 510 confocal microscope (x40, NA 1.3). B1 shows the staining with the ER
marker, CI shows a marker for endosomes. B2 and C2 show the EGFP-ENaC localization in
these cells. The merged images were placed in the panel B3 (B1+B2) and C3 (C1+C2). Note the
separation of ENaC localization from the ER in B3 and its separation from endosomes in C3.
ER ENaC Merged
Golgi ENaC Merged
Figure 5.5. Comparison of the EGFP-ENaCp subcellular localization to the ER and the Golgi apparatus in
polarized M-l epithelia. The fluorescence images of cell monolayers were captured by confocal
microscopy. The cells were labeled with the ER marker (Al) or with the anti-Golgi antibody (Bl). A2 and
B2 reveal the ENaC subcellular localization. The merged images were placed in the panel A3 (A1+A2)
and B3 (B1+B2). Note some co-localization of ENaC to the Golgi apparatus (B3).
presumably involving intracellular vesicles.
5.4.5 Corticosteroids promote ENaC translocation to the apical membrane
ofpolarizedM-l cells
Next I labeled the apical membrane ofpolarized M-l cells withWGA. To evaluate the
distribution of ENaC throughout the entire volume of the cells as a monolayer, I
acquired serial transverse optical sections from the top (apical) to the bottom (basal)
of the cells by confocal microscopy and generated 3D stack reconstruction of these
optical sections to allow a sagittal (side) view of the monolayer. In the control group
(lOpM RU486 and lOOnM Dex), I found little or no ENaC localization to the apical
membrane but high abundance of ENaC proteins in cytoplasm, especially the
subapical region (Figure 5.6 Al-3 and al-3). In contrast, stimulation with Dex
resulted in translocation of ENaC proteins to the apical membrane of M-l cells
(Figure 5.6 Bl-3 and cl-3). The effect was observed at concentrations of Dex as low
as lOnM and became more pronounced at lOOnM and lpM. With or without the
hormonal stimulation, the GFP fusion protein was not localized to the lateral
membrane of M-l cells (Figure 5.6 bl-3 and dl-3). In addition, I found ENaC
distribution on the apical surface ofM-l cells and the apical surface itself labeled with
WGA had a reticulated fluorescence pattern (Figure 5.6 cl-3). It is well established
that this pattern is caused by increased optical path lengths through the microvilli and
microridges compared with the flat areas on the apical membrane (Colarusso and
Spring, 2002). The microvilli and microridges cause diffraction errors that make the
apical plasma membrane one of the most difficult area of cells to study precise
localization by the sagittal reconstruction. To provide a clearer view of the sagittal
section of a monolayer, I rapidly froze the monolayer and performed the sagittal
sectioning of the monolayer with a cryostat to produce lOpm-thick sections. These
sections were thereafter visualized by confocal microscopy. Consistent with my
previous data supplied by analyzing the stack of optical sections, I observed
segregation of ENaC from the apical membrane in the control group as exemplified
by measuring the apical to basal fluorescence intensity profile (Figure 5.7A). In










































































Figure 5.6. Corticosteroid effects on ENaC trafficking. Confocal optical sections of polarized M-l cell
monolayers in the sagittal plane (A-B: 1-3) and in the transverse plane (a-d: 1-3) show a predominantly
subapical ENaC localization shitting apically into the plasma membrane in response to dexamethasone
treatment (lOOnM). The apical and lateral membranes of cells were labeled with the membrane marker
WGA (A-Bl and a-dl). A-B2 and a-d2 reveal the ENaC subcellular localization. The merged images were
placed in the panel A-B3 and a-d3. Note the abundance of ENaC proteins in the subapical region (A3) and
the apical translocation ofENaC (B3). Panels al-3 and cl-3 show a transverse optical section through the
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Figure 5.7. Apical movement of ENaC in M-l cell monolayers sagittally sectioned to allow a clearer and
more direct view from side (c.f. sagittal reconstruction images in Figure 5.6). Confocal microscopy images
show the sagittal view of localization of the EGFP-ENaC proteins (green) and the apical membrane (red)
in cell monolayers from the control group (A) and the Dex treatment group (B). The two-color
fluorescence intensity profiles across the monolayer in A and B are shown underneath the images. The
white arrow indicates where the representative intensity profiles were obtained. Note the shift of EGFP-
ENaC to overlapping with the apical membrane in response to dexamethasone treatments.
degree of overlap between ENaC and the apical membrane (Figure 5.7B).
5.5 Discussion
Understanding the process of ENaC trafficking and its hormonal regulation is of
fundamental importance. ENaC has three homologous subunits (a, (3 and y) and forms
a complex in a stoichiometry of 2a:ip:ly (Firsov et al. 1996, 1998). ENaC assembly
likely occurs in the ER (Adams CM et al. 1997) and the maximal surface expression
of the channel complex is reached only when all three ENaC subunits are expressed in
X. laevis oocytes (Canessa et al. 1994; Firsov et al. 1996). This indicates that if one
subunit is labeled with the enhanced green fluorescence protein (EGFP) and
expressed ectopically in the M-l cells (that express all three subunits endogenously),
it will replace some of the same subunit endogenously expressed and contribute to
forming the three-subunit complex with the other two subunits and serve as a
molecular tracer of the channel complex. Potentially each of the three subunits is a
candidate with which to tag EGFP. One earlier study has reported ENaC subcellular
localization and its trafficking in A6 cells by tagging EGFP to either a or |3 subunit
and obtained similar findings (Blazer-Yost BL et al. 2001). As part ofmy research aim
is to determine corticosteroids' influences on ENaC trafficking, it seems sensible to
avoid choosing the a subunit of ENaC as a candidate because the endogenous ENaCa
is itself transcriptionally upregulated by corticosteroids in the distal nephron cells
(Asher C et al. 1996; Escoubet B et al. 1997; MacDonald P et al. 2000) and the
constitutively expressed EGFP-ENaCa may obscure the stimulation of ENaCa by
corticosteroids and its contribution to ENaC trafficking. Moreover, corticosteroids
induce a shift in molecular weight of ENaCy from 85 kDa to 70 kDa, due to the
proteolytic clipping of the extracellular loop (Masilamani S et al. 1999). To avoid the
post-translational modification of EGFP tagged ENaCy, I have decided to use the P
subunit and generated the mouse collecting duct M-l cell lines stably expressing
EGFP-tagged ENaCp subunits.
I found ENaC fusion proteins had a distribution restricted to the endoplasmic
reticulum (ER) in these mammalian collecting duct cells as single unpolarized cells.
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This is consistent with previous studies conducted in Xenopus oocytes showing that
ENaC maturation is inefficient (Valentijin JA et al. 1998). Treatments for 24-h with
doses of dexamethasone ranging from lOnM to lpM had no effect on the
translocation of ENaC proteins in unpolarized M-l cells. It is possible that the action
of corticosteroids on ENaC depends upon the activation of proteins in the pathway
contributing to the epithelial polarization. Recent studies have shown potential cell
signaling molecules localized to the tight junction of cells or the regions of cell-cell
contact, including the small GTPase Ras and the p85 regulatory subunit of
phosphatidyl-inositol (PI) 3-kinase (Woo PL et al. 1999). Both Ras (Spindler B et al
1997, 1999) and PI3 kinase (Blazer-Yost BL et al 1998, 1999) are engaged in the
transduction of corticosteroid-driven sodium re-absorption in the distal nephron.
When cells were polarized, the EGFP-ENaC proteins exited the ER and the Golgi
apparatus and accumulated in punctate structures (presumably in intracellular vesicles)
in cytoplasm. Numerous studies have confirmed that there exists a cytoplasmic pool
of ENaC proteins (Morris RG et al. 1998; Hager H et al. 2001). Although I noticed
some co-localization of ENaC to the Golgi apparatus, it only represented a minority of
the chimeric ENaC proteins. This stands in contrast to other reports that ENaC is
extensively co-localized to the Golgi apparatus in the MDCK cells (a cell line with a
more proximal nephron ancestry) (Hanwell D et al. 2002). In addition, the exodus of
EGFP-ENaC out of the ER was virtually complete, indicating incorporation of EGFP-
ENaC into an efficient endogenous cell trafficking pathway.
Corticosteroids exert a profound impact upon the trafficking of ENaC proteins.
Though one early study analyzed ENaC trafficking in A6 cells by labeling ENaC in
the apical membrane with an anti-idiotypic antibody and showed that aldosterone
failed to alter the apical surface expression of ENaC (Kleyman TR et al. 1992), my
report is more consistent with more recent in vitro studies (Alvarez de la Rosa DA et
al. 2002) and in vivo studies (Loffing J et al. 2000, 2001; Masilamani S et al. 1999)
showing that translocation of ENaC proteins to the apical membrane follows
treatments elevating the corticosteroid concentration. Furthermore, my study is the
first one so far showing unequivocal imaging evidence of ENaC translocation to the
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apical membrane induced by corticosteroids by counter-staining the cell membrane.
Previous studies visualizing ENaC membrane expression lacked simultaneous
counter-staining of cell membrane (Loffing J et al. 2000, 2001; Masilamani S et al.
1999; Blazer-Yost BL et al. 2001). Both my findings and reports of other groups
showed that the accumulation of ENaC proteins did not occur on the basolateral
membrane in response to corticosteroid stimulation (Loffing J et al. 2000, 2001).
Previous studies have indicated that AVP (that signals downstream pathways via
cAMP) or forskolin (a direct activator of adenylate cyclase) stimulates the
translocation of ENaC to the apical surface. Kleyman et al (1994) addressed the effect
of AVP to promote ENaC trafficking to the apical membrane of A6 cells by labeling
ENaC with an anti-idiotypic antibody. Blazer-Yost BL et al (2001) used A6 cell lines
to express Xenopus ENaC subunits tagged to GFP. She demonstrated that forskolin
treatment produced an acute increase in the fluorescence labeled ENaC in the apical
membrane. My study is the first to dissect the subcellular events underpinning the
ENaC trafficking response to forskolin stimulation. I found that forskolin fostered the
exodus of ENaC out of the endoplasmic reticulum and entering intracellular vesicles.
These vesicles where ENaC resided were distinct from those involved in the
endocytic pathway as shown by the lack of their co-localization with transferrin-
labeled vesicles. This suggests that forskolin stimulates the exocytic transport of
ENaC, which is consistent with these earlier studies.
In conclusion, this study is the first to investigate the intracellular trafficking of ENaC
proteins in mouse collecting duct M-l cells as well as the first to generate M-l cell
lines stably expressing EGFP-fused ENaC proteins. Previous work has examined
ENaC trafficking in the Xenopus A6 cells, Xenopus oocytes, HEK-293 cells, COS
cells and MDCK cells that either endogenously or ectopically (usually transiently)
expressed ENaC. While these studies have contributed to our understanding of
channel trafficking, it is difficult to use such surrogate systems to study channel
trafficking when its endogenous regulators in mammalian distal nephron are largely
unknown and may be absent in other distinctly related cell types. As the current work
was conducted in cells derived from the mammalian distal nephron, it allows a clearer
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view of ENaC trafficking and its regulation by hormones. Additionally, M-l cells are
a well-established model for assessing the hormonal stimulation of sodium transport
(Stoos BA et al. 1991; Helms MN et al. 2003; Letz B et al. 1995; Chalfant ML et al.
1996; Nakhoul NL et al. 1998). Furthermore, this study gives novel insights by
determining the effect of epithelial polarization upon the intracellular localization of
ENaC proteins. ENaC localization is conspicuously dependent upon the state of
polarization. Not only does this suggest that the pathway involved in the cell
polarization may cross-talk with that regulating ENaC trafficking, but also it contrasts
with the view that trafficking of ENaC proteins may be governed by a universal
mechanism common to diverse cell types: from the non-epithelia (the Xenopus
oocytes), less differentiated renal cells (the HEK-293 cells) and fully differentiated
renal epithelial cells (the collecting duct cells) alike. Finally, polarization seems to be
a key factor in hormonal modulation of ENaC trafficking and appears to be a
prerequisite for corticosteroid induced apical trafficking of ENaC. I hypothesize a
pathway of ENaC trafficking and its response to corticosteroids. Firstly, an early
corticosteroid-independent stage may occur prior to polarization with ENaC exodus
from the ER to vesicles, forming a potentially mobile intracellular pool of ENaC.
Once cells become fully polarized, a second corticosteroid-dependent stage may then
follow in which corticosteroids promote ENaC translocation to the apical membrane.
The genes underpinning the first stage are largely unknown but the individual
molecular steps comprising the second stage have attracted much attention and clearly
involve corticosteroid induced proteins (CIPs). For example, sgkl, a kinase induced in
distal nephron by corticosteroids (Hou J et al. 2002) may be a key factor that
modulates the apical targeting of ENaC (Alvarez de la Rosa D et al. 1999).
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CHAPTER 6
THE ROLE OF SGK1 IN MODULATING ENAC CONDUCTANCE AND
TRAFFICKING AND GENERATION OF A CELL MODEL TO CONTROL
SGK1 EXPRESSION
6.1 Summary
The serine-threonine kinase sgkl was recently identified as a gene rapidly induced by
corticosteroids, resulting in increased sodium transport. In unpolarized distal nephron
M-l cells, I have found that sgkl has no effects on ENaC intracellular trafficking. In
addition, sgkl itself is localized to the intracellular compartment distinct from ENaC.
To elucidate the role of sgkl in modulating ENaC conductance, I have generated M-l
cell lines stably transfected with sgkl whose gene expression level is tightly
controlled by the tetracycline-inducible system. In these cell lines, sgkl gene has no
'leaky' expression and its gene induction is highly responsive to tetracycline (10-fold
induction at <10ng/ml versus lOpg/ml). This model can become available and widely
accessible to determine whether upregulation of sgkl by tetracycline influences
ENaC-mediated sodium reabsorption in parallel to that by corticosteroids.
6.2 Introduction
The serum and glucocorticoid kinase 1 (sgkl) was first identified as an aldosterone
induced protein in vitro in amphibian (Chen SY et al. 1999) and mammalian cell lines
(Naray-Fejes-Toth A et al. 1999) and later in vivo in rat (Brennan FE and Fuller PJ.
2000; Bhargava A et al. 2001) and mouse kidneys (Hou J et al. 2002). When co-
injected with ENaC subunits into Xenopus oocytes, sgkl significantly elevates the
ENaC-mediated sodium transport and the surface expression of ENaC subunits (Chen
SY et al. 1999; Alvarez de la Rosa D et al. 1999). Over-expression of sgkl in Xenopus
A6 cell line (Faletti CJ et al. 2002; Alvarez de la Rosa D and Canessa CM. 2003) and
mouse M-l cell lines (Helms MN et al. 2002) increases the basal level of sodium
transport by 2-5 fold. These studies suggest that sgkl may be a critical component in
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the pathway of aldosterone to the hormone driven sodium reabsorption.
How sgkl modulates ENaC conductance and its surface expression is largely elusive.
Initial thoughts about the mechanism of sgkl's action included the notion that it
directly interacted with ENaC to dynamically regulate ENaC insertion into and/or
retrieval from the apical membrane. Indeed, Sgkl physically interacts with the COOH
termini of both a- and P-ENaC, when the latter proteins are expressed as glutathione
S-transferase fusion proteins (Wang J et al 2001). Snyder and colleagues (Snyder PM
et al 2002) recently showed that sgkl phosphorylated the ubiquitin ligase NEDD4-2
to inhibit the latter's function and its binding to ENaC, which was independently
confirmed by Debonneville and colleagues (Debonneville C et al 2001). The reduced
binding of NEDD4-2 to ENaC leads to a subsequent decrease in the rate of ENaC
endocytosis from the cell surface and thus prolongs the half-life of ENaC. This view
of sgkl's suppressing ENaC endocytosis is further complicated by the fact that sgkl's
homologue in S. cerevisiae (Ypkl) is required for both receptor-mediated and fluid-
phase endocytosis (DeHart A et al. 2002).
Previous studies of determining sgkl's effects on ENaC conductance and protein
trafficking were mostly conducted in Xenopus oocyte expression system. In this study,
I aim to first answer whether sgkl alters ENaC subcellular localization in distal
nephron M-l cells. Second, I aim to answer whether sgkl co-localizes with ENaC in
M-l cells. Finally, I aim to generate a cell model in which the expression of sgkl can
be tightly regulated by the tetracycline inducible system. This model can become
available and widely accessible to determine whether upregulation of sgkl by




6.3.1 ENaC is confined to the endoplasmic reticulum when co-transfected
with sgkl in unpolarizedM-l cells
In Chapter 5.4.2, I have shown ENaC is confined to the endoplasmic reticulum in
unpolarized M-l cells. To determine sgkl's effects on the localization of ENaC
protein in unpolarized M-l cells, I sparsely seeded cells onto glass coverslips and co-
transfected cells with EGFP-ENaCP and sgkl at the molar ratio of 1:1, 1:2 and 2:1
48h prior to fixation. As shown in Figure 6.1A, sgkl co-transfection with EGFP-
ENaCp did not alter the intracellular localization of ENaC. ENaC had a cytoplasmic
reticular distribution suggestive of the endoplasmic reticulum (ER). Counterstaining
the ER membrane with the rhodamine-B hexyl ester revealed the localization of
ENaC in the ER (Figure 6.1a-c).
6.3.2 Sgkl and ENaC are localized to distinct intracellular compartments
To determine whether sgkl co-localizes with ENaC in unpolarized M-l cells, I co-
transfected cells with EGFP fused ENaCp and HcRed (red fluorescence protein) fused
sgkl. Merging the channel of EGFP fluorescence (Figure 6.2 Al) with the HcRed
fluorescence (Figure 6.2 A2) indicated that sgkl was localized largely to some
intracellular compartment distinct from that of ENaC (i.e. the ER), probably in
cytosol (Figure 6.2 A3).
6.3.3 Generation oftetracycline-inducible expression ofsgkl in M-l cells
The tetracycline-inducible (Tet) system (Gossen M and Bujard H. 1992) was used to
regulate the expression level of sgkl in M-l cells (Figure 6.3). The first critical
component of the Tet system is the regulatory protein (named tetracycline
transactivator or tTA encoded by pTet-Off), a 37-kDa fusion protein made of the
E.coli DNA binding protein (TetR) and the Heipes simplex virus VP16 activation
domain. The second component is the response plasmid (TRE-EYFP-sgkl) that
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ER ENaC Merged
Figure 6.1. Sgkl effect on ENaC trafficking in unpolarizedM-l cells. UnpolarizedM-l cells were co-transfected
with EGFP-ENaCP and sgkl. The fluorescence image of M-l cells (A) was captured by the Zeiss Axio-
epifluorescence microscope (xlOO, NA 1.4); and images (a-c) by the Zeiss 510 confocal microscope (x40, NA
1.3). Panel a shows the staining with the ER marker; b the localization of ENaC and the merged image was
placed in the panel c. Note the confinement of ENaC in ER in the presence of sgkl expression.
ENaC Sgk1 Merged
A1 A2 A3
Figure 6.2. Studies of the intracellular localization of ENaC and Sgkl. Unpolarized M-l cells were co-
transfected with EGFP-ENaC(3 and HcRed-sgkl. The fluorescence images (Al-3) were captured by the Zeiss
510 confocal microscope (x40, NA 1.3). Panel A1 shows the localization of ENaC; A2 the localization of sgkl
and the merged image was placed in the panel A3. Note the lack of co-localization between ENaC and sgkl.
1TA
Figure 6.3 Schematic of the expression vector plasmid and the mechanism of tetracycline-inducible
system. PCMV, cytomegalovirus immediate early promoter; PminCMV, minimal cytomegalovirus
promoter; TRE, tetracycline responsive element; tTA: tetracycline transactivator; EYFP: enhanced
yello fluorescence protein; SGK: serum and glucocorticoid kinase; Tet: tetracycline.
expresses enhanced yellow fluorescence protein (EYFP) fused sgkl under control of
the tetracycline-response element, or TRE. TRE consists of seven direct repeats of a
42-bp Tet operator sequence (TetO), and is located just upstream of the minimal CMV
promoter that lacks the strong enhancer elements normally associated with the CMV
immediate early promoter. Because these enhancer elements are missing, there is no
'leaky' expression of EYFP-sgkl from TRE. tTA stimulates the transcription of
EYFP-sgkl by binding to TetO in the absence of tetracycline. Addition of
tetracycline prevents the binding of tTA to TetO and thus silences gene expression.
The making of tetracycline inducible cell lines involved two rounds of transfection
and selection of stable clones. On the first round, M-l cells were transfected with the
construct pTet-Off that expressed tTA from the CMV immediate early promoter. Out
of 30 cell lines selected, one was chosen with the highest fold-induction of transient
EYFP-sgkl expression and thus named tTA-M-1. Next round, tTA-M-1 cells were
transfected with the construct TRE-EYFP-sgkl and grown in the presence of 1 pg/ml
tetracycline. Among the 50 cell lines screened through, I analyzed two cell lines
showing highest fold-induction of stable EYFP-sgkl expression and focused on one
cell line in the following experiments.
6.3.4 Characterization of the transgenic cell lines.
To verify that EYFP-sgkl gene was expressed in the clonal cell lines and tightly
regulated by tetracycline, I analyzed the EYFP fusion protein product by western
blotting. When medium was depleted with tetracycline (ON status), a distinct band
with a molecular weight of ~80kDa was detected on the PVDF membrane probed
with an anti-EYFP antibody (Figure 6.4). The 24-h treatment with 1 pg/ml tetracycline
(OFF status) effectively silenced EYFP-sgkl's expression. The parental M-l cells did
not contain a similar epitope. Examination of the fluorescence micrograph (Figure
6.5A) of the M-l cells revealed that the sgkl fusion gene had no 'leaky' expression
and was highly stimulated upon removal of tetracycline. At high magnification the
fluorescence imaging of sgkl fusion proteins showed a diffuse cytoplasmic pattern
lacking the appearance on nuclear envelope and a reticular structure (Figure 6.5B),













Probed with an anti~EG(Y)FP antibody
Figure 6.4. Western blotting analysis of the EYFP-sgkl stable cell lines. The position of the
molecular weight standards (in kDa) was shown at left. When medium was depleted with
tetracycline (ON status), a distinct band with the molecular weight of ~80kDa was found in
the stable cell lines (EYFP-sgkl-1 and -2) but not in the control (parental M-l cells). The
24-h treatment with lpg/ml tetracycline (OFF status) effectively silenced EYFP-sgkl's
expression. The expression of EGFP-ENaC|3 was used as a positive control.
Figure 6.5. Fluorescence images of the M-l cells expressing EYFP-sgkl proteins. Cells
were grown on coverslips, fixed and mounted as described under Methods . Fluorescence
images were captured by the Zeiss Axio-epifluorescence microscope (A: xl6, NA 0.5; B:
xlOO, NA1.4). Note the sgkl fusion proteins have a diffuse cytoplasmic distribution (B:
arrow).
with a range of doses of tetracycline (Tet: lOpg/ml, 1 pg/ml, lOOng/ml, lOng/ml and
lng/ml and 0). The analysis by FACS revealed that the expression level of EYFP-
sgkl was dependent upon the dose of tetracycline (removal of tetracycline) in two
ways: (1) the percentage of EYFP expressing cells increased, even though the
heterogeneity of EYFP fluorescence level existed in this cell line (Figure 6.6); (2) the
absolute EYFP fluorescence level increased, showing a maximum of 10-fold
induction at the tetracycline concentration of <lng/ml (p<0.001 versus 1 Oug/ml)
(Figure 6.7). In addition, the cell line exhibited high transepithelial resistance (>1,000
LFcm2) when fully polarized after 7-10 days. Tetracycline-induced sgkl expression
had no effect on transepithelial resistance (1.715±0.127kQ at 0 tetracycline compared
to 2.370±0.28kF2 at lOpg/ml tetracycline, p=0.260, n=6).
6.4 Discussion
The mechanism of sgkl's influences on ENaC conductance has been elusive so far.
Previous attempts to elucidate sgkl's function have been mostly carried out in
Xenopus oocytes. In oocytes, sgkl increases the number of ENaC in the plasma
membrane independently of overt effects on the gating kinetics of this channel (De La
Rosa DA et al 1999; Loffing J et al 2001; Wagner CA et al 2001). In contrast, I have
found sgkl has no effects on ENaC intracellular trafficking in unpolarized distal
nephron M-l cells. This is consistent with my previous findings and hypothesis
(Chapter 5) that polarization is a prerequisite for corticosteroid induced membrane
trafficking of ENaC and furthermore indicates that polarization may have to be
fulfilled so that sgkl functions to link corticosteroids to stimulated ENaC trafficking.
Though sgkl has been shown to physically interact with ENaC a and P subunits in
vitro (Wang J et al 2001), my findings suggest that in distal nephron cells sgkl and
ENaC p are actually localized to distinct intracellular compartments. It is possible that
the physical association between sgkl and ENaC is transient or only occurs between a
minority of proteins. Sgkl may compete with Nedd-4-2 to bind to ENaC and thus
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Figure 6.6. FACS analysis of the dose dependence of EYFP-sgkl expression upon
tetracycline. M-l cells were treated for 24-h with a range of doses of tetracycline (Tet:
lOug/ml, lug/ml, lOOng/ml, lOng/ml, lng/ml and 0). Note the percentage of EYFP
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Figure 6.7. Quantification of EYFP-sgkl expression in response to tetracycline. M-l
cells were treated for 24-h with a range of doses of tetracycline (Tet: 10|Jg/ml,
lpg/rnl, lOOng/ml, lOng/ml, lng/ml and 0). Note the induction of EYFP expression
level when tetracycline is removed.
I have reported for the first time the generation ofmouse collecting duct cell lines (M-
1) that stably express sgkl whose gene expression level is tightly controlled by the
tetracycline-inducible system. In these cell lines, sgkl gene has no 'leaky' expression
and its gene induction is highly responsive to tetracycline. In addition, this cell line
grows normally and forms high transepithelial resistance when becoming fully
polarized. Sgkl over-expression had no effect on transepithelial resistance of cells,
suggesting sgkl is not involved in modulating ion transport via the paracellular
pathway (Zahraoui A et al 2000). My preliminary studies have also found no effects of
sgkl induction upon transepithelial potential difference (TPD) (2.483±0.079mV at 0
tetracycline compared to 2.540±0.312mV at lOpg/ml tetracycline, p=0.66, n=6).
Theoretically, ionic equilibrium potentials (IEP) vary logarithmically with the ion
concentration ratio between the apical side and the basal side (Boltzmann/Nernst
equation). TPD is the sum of IEP of all ions present (including Na+, K+, CI", Ca2+ et al)
and in fact reflects the 'difference' of concentration of ions between the two sides,
which is in turn determined by the conductivity of every ion transporter (including
channels, Na+/K+-ATPase, co-transporters and exchangers). Ideally, if sgkl only
affects the transport of Na+ via ENaC on the apical membrane of distal nephron,
sodium concentration will increase in the basal medium at equilibrium, which will
therefore elicit a change in TPD. Nevertheless, it has been found that sgkl modulates
the conductivity of a number of ion transporters [including ROMK (Kirl.l, a K+
channel expressed on the apical surface of distal nephron: Yoo D et al 2003), Kvl (a
voltage gated K channel in brain: Gamper N et al 2002), NHE3 (sodium hydrogen
exchanger 3 in proximal tubules: Yun CC et al 2002) and NKCC2 (Na+/K+/2CT
cotransporter 2 in thick ascending limbs: Lang F et al 2000)]. The complex effects of
sgkl on ion transport make it illicit to attribute TPD changes to changes in Na+
transport alone. Thus further studies to elucidate the influences of sgkl on sodium
reabsorption may require a more sensitive and accurate approach of electrophysiology
(for example, perfusing the cell monolayer with medium containing single cation in
Ussing chambers and detecting short-circuit current or 22Na+ current by adding an
external electric field to offset TPD).
Potentially, this cell model can be used to elucidate the influences of sgkl upon ENaC,
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Na+/K+-ATPase, ROMK and others. Electrophysiological approach will provide
functional data on transporter conductivity. The answer to how sgkl modulates the
trafficking of these ion transporters can be sought by approaches of cell biology. A
modified protocol based upon Firsov D et al (1996) could be followed to develop a
quantitative method to measure the surface expression level of transporter proteins, in
which a hemagglutinin (HA) epitope is inserted into the extracellular loop of
transporter. The level of HA expression detected by immunofluorescence reflects the
amount of transporter proteins on the cell surface.
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CHAPTER 7 DISCUSSION
Aldosterone is the primary hormone responsible for maintaining sodium reabsorption
in the distal nephron of kidney. The Na+ transport induced by aldosterone, is handled
via the epithelial Na+ channel (ENaC) (Rossier BC 1997; Horisberger JD 1998). The
early phase of aldosterone action is often demarcated as the period when the pre¬
existing ENaC channels in the plasma membrane are activated; and the late phase
(>3h) is when de novo synthesis of ENaC and its translocation to the plasma
membrane take place (Verrey F et al 2000). Aldosterone influences expression of a
broad pool of genes, the protein products of which transduce the actions of
aldosterone in the nucleus out to the plasma membrane where its final effector ENaC
is located. The first two aims of my PhD studies were to identify and characterize the
genes that are transcriptionally regulated by aldosterone in the distal nephron. The
strategy to achieve these aims involved: 1, systematically screening a large pool of
candidate genes including those playing a pivotal role in the aldosterone pathway
(MR and 11|3-HSD2), those discovered by others and shown to be regulated by
aldosterone (such as sgkl and K-Ras) and those generated in the host laboratory; 2,
focusing upon the gene sgkl and its regulation by aldosterone in the distal nephron to
elucidate whether regulation of sgkl expression is consistent with its playing a role in
transduction of aldosterone-driven sodium reabsorption.
The serine-threonine kinase sgkl was first identified as a gene rapidly induced by
aldosterone in the Xenopus A6 cell line, resulting in increased sodium transport in
vitro (Chen SY et al. 1999). Others have confirmed the upregulation of sgkl by
aldosterone in the cell line derived from the distal nephron of rat, rabbit and mouse
(Shigaev A et al 2000; Naray-Fejes-Toth A et al 1999). These in vitro findings identify
sgkl as a good candidate gene in hormonal regulation of sodium transport in cells of
distal nephron. My research objective in achieving significant results was to
determine the distribution of sgkl in intact kidney and study its hormonal regulation
in vivo. Although there have been some in vivo studies carried out previously, their
research plans were limited to investigating the short-term (0.5hr-4hr) effect of
aldosterone on sgkl expression (Chen SY et al. 1999; Brennan FE and Fuller PJ 2000;
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Bhargava A et al. 2001). In my thesis, I have determined the effect of aldosterone on
sgkl expression in both short term (acute) and long term (chronic)
hyperaldosteronism. I have also examined the regulation of sgkl by aldosterone in
substantial detail including the dose response and cellular localization.
In kidney of control mice, I found an abundant expression of sgkl in glomeruli and
inner medullary collecting ducts, which was maintained independent of
corticosteroids and thus persisted in adrenalectomized animals. I find in mice both
acute and chronic aldosterone infusions induced sgkl expression in the distal nephron
(including the distal tubules through to the outer medullary collecting ducts). These
regions have the potential to mediate amiloride-sensitive sodium transport, as they are
the major sites of ENaC action. Most importantly, my work has shown for the first
time an axial heterogeneity of prolonged upregulation of sgkl mRNA, which
correlates with the plasma level of aldosterone across groups on low-sodium diet to
low-dose and high-dose aldosterone infusions. It appeared that mild aldosterone
excess (0.03% sodium diet) induced sgkl in the cortical portion of distal nephron
whereas moderate (50pg/kg infusion) and more severe (150pg/kg and 750pg/kg
infusions) excess affected the entire distal nephron. This heterogeneity of sgkl
expression would eventually translate to heterogeneity of sgkl modulation of sodium
transport along the distal nephron.
My study is so far the first to assess sgkl regulation using in situ hybridization in
mouse as well as the first to carefully quantify the degree of its induction in different
parts of the nephron (distal tubules, glomeruli and inner medulla) using silver-grain
counting. The upregulation of sgkl rnRNA exhibited dose dependence in individual
renal tubules over a range of circulating aldosterone (2 to 75-fold elevation). The fact
that the induction of sgkl exhibited a ceiling (8-fold elevation) in animals with severe
aldosterone excess suggests that the aldosterone-sgkl-ENaC pathway responses reach
saturation at this level. It is possible that this is due to saturation of available MR sites.
Potentially this mechanism may contribute to the 'escape' of kidney from aldosterone-
induced Na retention (i.e. the reaching of the ceiling of sgkl expression translates to
the peaking of sodium reabsorption induced by sgkl and its related pathway).
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The next two aims of my PhD studies involve elucidation of the function of sgkl.
Previous studies have shown that when co-injected with ENaC subunits into Xenopus
oocytes, sgkl significantly elevates the ENaC-mediated sodium transport and the
surface expression of ENaC subunits (Chen SY et al. 1999; Alvarez de la Rosa D et al.
1999). It has long been thought that sgkl links aldosterone to the hormone driven
sodium reabsorption in distal nephron cells. The mechanism of sgkl actions is largely
elusive. A number of recent studies suggest that sgkl mediates exocytosis (Alvarez de
la Rosa D et al. 1999) or endocytosis (Debonneville C et al 2001; Snyder PM et al
2002) of ENaC in Xenopus oocytes. Thus it has attracted much attention to investigate
ENaC trafficking in mammalian distal nephron cells and its modulation by hormones
(primarily corticosteroids) and the key genes underpinning the corticosteroid driven
pathway (especially sgkl).
To achieve my objectives of elucidating the role that sgkl plays in ENaC-mediated
sodium transport and ENaC trafficking, I, at the first step, have generated the mouse
collecting duct M-l cell lines stably expressing EGFP-tagged ENaCp subunit and
investigated its intracellular trafficking and the influences of epithelial polarity and
corticosteroids. The second step involves investigating the effects of sgkl on ENaC
trafficking and generation of a cell model in which the expression of sgkl is tightly
regulated by the tetracycline inducible system. This model is valuable in determining
whether upregulation of sgkl by tetracycline influences ENaC-mediated sodium
reabsorption in parallel to that by corticosteroids.
I have found that EGFP-fused ENaCp proteins had a distribution restricted to the
endoplasmic reticulum (ER) in M-l cells as single unpolarized cells. This is consistent
with previous studies conducted in Xenopus oocytes showing that ENaC maturation is
inefficient (Valentijin JA et al. 1998). Treatments for 24-h with doses of
dexamethasone ranging from lOnM to lpM had no effect on the translocation of
ENaC proteins in unpolarized M-l cells. When cells were polarized, the EGFP-ENaC
proteins exited the ER and the Golgi apparatus and accumulated in punctate structures
(presumably in intracellular vesicles) in cytoplasm. Numerous studies have confirmed
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that there exists a cytoplasmic pool of ENaC proteins (Morris RG et al. 1998; Hager
H et al. 2001). Corticosteroids (lOOnM Dex) exert a profound impact upon the
trafficking of ENaC by promoting its translocation to the apical plasma membrane.
The accumulation of ENaC proteins did not occur on the basolateral membrane in
response to corticosteroid stimulation.
The novelty and significance of my research on ENaC trafficking are that my study is
so far the first to determine the effect of epithelial polarization upon the intracellular
localization of ENaC proteins. ENaC localization and its regulation by corticosteroids
are conspicuously dependent upon the state of cell polarization. Not only does this
suggest that the pathway involved in cell polarization may cross-talk with that
regulating ENaC trafficking, but also it contrasts with the more traditional view that
trafficking of ENaC proteins is governed by a universal mechanism common to
diverse cell types: from the non-epithelia (the Xenopus oocytes), less differentiated
renal cells (the HEK-293 cells) and fully differentiated renal epithelial cells (the
collecting duct cells) alike. I hypothesize a pathway of ENaC trafficking and its
response to corticosteroids. Firstly, an early corticosteroid-independent stage may
occur prior to polarization with ENaC exodus from the ER to vesicles, forming a
potentially mobile intracellular pool of ENaC. Once cells become fully polarized, a
second corticosteroid-dependent stage may then follow in which corticosteroids
promote ENaC translocation to the apical membrane.
In unpolarized M-l cells, I have found that sgkl did not alter the intracellular
localization of ENaC. This is consistent with my previous findings and hypothesis that
polarization is a prerequisite for corticosteroid induced ENaC trafficking and indicates
that polarization may have to be fulfilled so that sgkl functions to link corticosteroids
to stimulated ENaC trafficking.
Remaining questions that can now be addressed are how sgkl influences ENaC
trafficking or conductance in polarized M-l cells. In this regard, the cell model I have
generated is valuable, in which the expression of sgkl is regulated by tetracycline (10
fold expression induction). A run of good experiments follows to elucidate: 1, the
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substrate of sgkl; 2, the influences of sgkl on ENaC conductance; 3, the influences of
sgkl on ENaC trafficking.
1, though Snyder P et al (2002) and Debonneville C et al (2001) have recently
shown that sgkl phosphorylated the ubiquitin ligase NEDD4 2 in vitro, it is worth
testing whether sgkl phosphorylates NEDD4-2 in vivo in the inducible cell model,
providing the development of antibodies against phosphorylated NEDD4-2;
2, to examine the effects of sgkl inducible expression on sodium transport
[both the transepithelial sodium transport (using Ussing's principles and Ussing
chambers) and the amiloride sensitive sodium transport across the apical plasma
membrane (using patch clamping)] in M-l cells is paramount and indispensable in
regarding sgkl as an essential step in corticosteroid signaling pathways;
3, to elucidate the influences of sgkl on ENaC trafficking in polarized
epithelia is an intriguing topic but is technically demanding. A quantitative method to
measure the surface expression level of ENaC is required to show unequivocally the
effects of sgkl. Amodified protocol based upon Firsov D et al (1996) can be followed
to solve this problem, in which a hemagglutinin (HA) epitope is inserted into the
extracellular loop of EGFP-ENaCp. The level of HA expression detected by
immunofluorescence reflects the amount of ENaC proteins on the apical surface
whereas the level of EGFP expression correlates to the amount of ENaC proteins in
total.
In conclusion, the outcomes ofmy PhD studies have contributed to our understanding
the signaling pathway of aldosterone and its influences on sodium transport in the
distal nephron. It has also shed light on how transmembrane proteins such as sodium
channels translocate to and from various intracellular organelles; and how this process
is regulated by hormones and genes whose products mediate the transduction of
hormonal signals to altered trafficking events.
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